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ABSTRACT
Identification of Chlamydial Iron-Responsive Proteins During Intracellular Growth
by
Brian D. Dill

Chlamydia trachomatis is an obligate intracellular bacterium and the most prevalent
cause of bacterial sexually transmitted disease. Genital chlamydial infections, marked
by chronic, intense inflammation, can lead to genital tissue scarring and infertility and is
a contributing factor to development of pelvic inflammatory disease and ectopic
pregnancy. Iron is required as a cofactor for numerous highly conserved pathways, and
nearly all studied organisms rely on iron for growth. In response to iron restriction, the
chlamydial developmental cycle arrests at the intracellular reticulate body stage,
resulting in a phenomenon termed persistence. Persistence likely plays a role in
chlamydial pathogenesis through the expression of virulence factors and antigens in
addition to sustaining chronic infection; however, little is known concerning how
chlamydiae respond to iron limitation at the molecular level, and no systems for iron
acquisition have been identified in Chlamydia. This dissertation presents an
investigation into the chlamydial response to iron restriction. Chlamydial heat shock
protein 60 (cHsp60) has been implicated in development of the more severe disease
sequelae and has been found to increase in expression following iron restriction;
however, three cHsp60 homologues were identified following the sequencing of the
chlamydial genome. Here, iron restriction is shown to increase expression of cHsp60-2
but not the two other homologs, cHsp60-1 or –3. Next, in order to investigate an
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alternate model for restricting iron availability to chlamydiae, a cell line with inducible
expression of recombinant ferroportin, a eukaryotic iron efflux protein, was examined.
Lastly, 10 chlamydial proteins differentially expressed during growth in iron-restricted
host cells were identified by proteomic analysis of radiolabeled proteins followed by
mass spectrometry analysis; transcripts encoding 5 iron responsive proteins were
examined across a timecourse of infection and revealed increased transcript levels at
18 and/or 24 hours post infection. Together, these studies have examined the
molecular response of chlamydiae to reduced iron availability and have underlined the
importance for pathways involved in protection against oxidative damage and
adaptation to stress.
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CHAPTER 1

INTRODUCTION

Chlamydia trachomatis is a Gram-negative, obligate intracellular bacterial
pathogen that infects the mucosal epithelium. C. trachomatis is divided into the
trachoma and lymphogranuloma venereum (LGV) biovariants, and the trachoma biovar
is further separated into serovariants A-K, based on antiserum specificity to the variable
region of the major outer membrane (MOMP). Serovars A-C infect the conjunctiva,
causing trachoma, the leading cause of preventable blindness worldwide (Thylefors and
others 1995), while trachoma serovars D-K are non-invasive pathogens of the genital
tract. The LGV biovar causes an invasive sexually transmitted disease (STD) found
primarily in tropical areas of the world.
Chlamydial infection is the number one bacterial STD in the world, with 92 million
new infections each year (World Health Organization 2001). Over 1 million new cases
of chlamydial infection in the United States were reported to the Centers for Disease
Control and Prevention in 2006, triple that of the next most common bacterial STD,
Neisseria gonorrhoeae; the estimated total number of actual new chlamydial infections
in the US is 3 million per year (Centers for Disease Control and Prevention 2007). The
chlamydial infection rate among adolescent females (24.1% to 27%) is alarming,
especially considering the potential for long-term effects on reproductive health (World
Health Organization 2001).
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Non-invasive chlamydial genital infections initially cause urethritis or cervicitis;
sequelae include prostatitis and epididymitis in men, and salpingitis, endometritis, pelvic
inflammatory disease, infertility, and ectopic pregnancy in women (Schacter 1999). The
initial infection is often asymptomatic, which allows infections to go undetected and thus
untreated, providing further spread. Invasive genital infections caused by LGV progress
from infection of the genital mucosa through the basal membrane to infection of
macrophages. Next, macrophages carry chlamydiae to the inguinal lymph nodes,
where a severe lymphoadenopathy can develop.
Another human chlamydial pathogen of note is Chlamydophila pneumoniae, a
respiratory pathogen responsible for a “walking pneumonia”. Chlamydophila
pneumoniae was reclassified from Chlamydia pneumoniae following ribosomal RNA
phylogenetic analysis. Not identified until the 1980s, C. pneumoniae is a ubiquitious
pathogen, with a world-wide seroprevalence of 60-70% (Schachter 1999). After
culturable C. pneumonia was recovered from atherosclerotic plaques, numerous studies
have implicated infection with C. pneumoniae and the progression of heart disease
(Saikku and others 1988; Hoymans and others 2007).
The first line treatment for a C. trachomatis genital infection is a single 1 g oral
dose of azithromycin or 100 mg of doxycycline twice daily for 7 days (Centers for
Disease Control and Prevention 2006). Antibiotic resistance has never been identified
in human chlamydial strains; however, a naturally-occurring tetracycline resistant strain
of the porcine chlamydial pathogen, Chlamydia suis, has been isolated (Lenart and
others 2001).
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Chlamydiae exhibit a biphasic developmental cycle involving transition between
the elementary body (EB) and the reticulate body (RB). The EB (0.3 µm) is the
infectious, metabolically inert form responsible for extracellular stability, attachment, and
entry (Figure 1.1A). In order to fulfill this role, the outer membrane is stabilized by
cross-linking of outer membrane proteins via disulfide bonds, and the chromosome is
condensed by chromatin-like proteins (Abdelrahman and Belland 2005). EB enter the
host cell by receptor-mediated endocytosis; primary binding may involve heparin sulfate
on the host cell surface, followed by a secondary, irreversible binding step. Although
secondary attachment involves an unknown chlamydial ligand and eukaryotic receptor,
numerous candidates have been proposed; evidence also indicates chlamydiae may
use multiple uptake pathways, depending on chlamydial strain and host cell type
(Dautry-Varsat and others 2004; Dautry-Varsat and others 2005). Upon attachment, the
chlamydial protein Tarp is secreted into the host cell cytosol via the putative type three
secretion system, resulting in the recruitment of actin and may play a role in entry or
early events following entry (Clifton and others 2004).
After entry, the EB convert within the endosomal vacuole into the metabolically
active 1 µm RB form. The chlamydial endosome, which following chlamydial
modification is known as the inclusion, is altered in order to change from the endocytic
pathway to the exocytic pathway, thus avoiding lysosomal fusion and consequent
acidification (Fields and Hackstadt 2002). Inclusions undergo homotypic fusion (in most
strains) and traffic to the perinuclear region. After undergoing a 6-14h lag phase, RB
replicate by binary fission (Figure 1.1B). In response to an unknown cue, the RB
convert asynchronously back to EB, which after host cell lysis or extrusion of the
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inclusion (Hybiske and Stephens 2007) allows the spread of infectious progeny to new
cells. The duration of the chlamydial developmental cycle differs by species and
serovar; that of the C. trachomatis trachoma biovar is approximately 60-72 h, the LGV
biovar is ~48h, and C. pneumoniae is ~96 h.

A

B

Figure 1.1. Transmission electron microscopy of (A) EB attaching to the epithelial cell
surface and entering via nascent endocytotic vesicles, and (B) RB growing inside an
inclusion at 36 hpi (photomicrographs courtesy of Jane Raulston).

The biphasic cycle can be interrupted at the RB stage in a phenomenon termed
persistence (Figure 1.2). During persistence, the RB cease to divide, become
extremely enlarged, and accumulate chromosomes. Infectivity is severely attenuated,
because infectious EB are not produced. Great interest in chlamydial persistence has
developed due to its potential role in producing chronic infections and pathogenesis,
particularly because persistent chlamydiae may be refractory to antibiotic killing,
allowing the continuation and spread of infection even after the patient has received
treatment, and increased expression of virulence factors by persistent chlamydiae may
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contribute to a prolonged inflammatory response (Hogan and others 2004).
Pathogenesis in Chlamydia is considered to be immune-mediated, although whether
this results from an antigen-dependent delayed-type hypersensitivity, autoimmunity, or a
chronic, intense inflammatory response to infection is debated (Stephens 2003).

Figure 1.2. The chlamydial developmental cycle, including persistence (diagram
courtesy of Jane Raulston)

There have been numerous inducers of persistence identified, including
interferon-γ exposure, penicillin exposure, amino acid (tryptophan) limitation, viral coinfection, and, most relevant to this dissertation, iron limitation (Raulston 1997; Hogan
and others 2004; Deka and others 2006). A study by Raulston (1997) established the
induction of chlamydial persistence via iron restriction, using the pharmaceutical agent
Desferal, which is used to treat patients with iron overload disorders (Raulston 2006).
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The iron-chelating compound Desferal is derived from Streptomyces pilosus (Muller and
Raymond 1984).
The first paper investigating the effect of iron restriction on chlamydiae examined
Chlamydophila (formerly Chlamydia) psittaci, a strain that infects avian species,
following exposure to Desferal. In C. psittaci-infected Desferal-exposed macrophages,
no decrease in inclusion number was found (Murray and others 1991). However, when
Raulston (1997) examined Chlamydia trachomatis-infected HEC-1B cells (a human
endometrial epithelial carcinoma cell line) exposed to Desferal, inclusion numbers were
not reduced, but inclusion size decreased and alterations in chlamydial (i) morphology,
(ii) infectivity, and (iii) protein expression profile were observed.
Chlamydiae exposed to Desferal exhibited an enlarged, aberrant RB morphology
typical of that seen in reported persistent chlamydial infections from exposure to
interferon-γ or penicillin (Beatty and others 1993). Chlamydial infectivity dropped 8-fold
in Desferal-exposed cultures, as determined by the percentage of cells containing
inclusions after inoculation using progeny EB at a given dilution (Raulston 1997).
Furthermore, supplementing Desferal-exposed, infected cultures with iron-loaded
transferrin restored infectivity of progeny EB. To determine if iron restriction altered the
chlamydial proteome, chlamydiae were radiolabeled in cultures with or without Desferal,
and EB were harvested and Renografin purified. EB proteins were solubilized and
separated by two-dimensional polyacrylamide electrophoresis (2D-PAGE), a method
that separates proteins based on isoelectric point (pI) and molecular weight, thus
producing a two-dimensional array of proteins. In comparing spot intensities between
2D gels from Desferal-exposed and unexposed cultures, 19 protein species were found
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to increase in expression; of these proteins, Hsp60 (heat shock protein 60), YtgA (a
putative ABC metal transporter), Pgk (phosphoglycerate kinase), and YscN (associated
with the type III secretion system apparatus) were identified (Raulston 1997). The
discovery that YtgA and Hsp60 are iron responsive was significant, because YtgA is a
putative component of an ABC iron transporter (Raulston and others 2007) and Hsp60,
a chaperone responsible for folding newly synthesized or denatured proteins into the
correct secondary structure, has repeatedly been implicated in a role in the
inflammatory damage of chlamydial pathogenesis (LaVerda and others 1999).
The requirement of chlamydiae for iron is not surprising because iron is a
cofactor required for a number of ubiquitous cellular metabolic processes in both
bacterial and eukaryotic cells, including cytochromes, ribonucleotide reductase, RNA
polymerase III, amino acid hydroxylases, superoxide dismutase, and catalase
(Wooldridge and Williams 1993; Andrews and others 2003). Iron serves as an electron
bank, donating or accepting electrons in order to catalyze oxidation and reduction
reactions. All examined organisms require iron except lactobacilli (Archibald 1983;
Weinberg 1997) and Borrelia burgdorferi (Posey and Gherardini 2000), which substitute
alternative transition metal cofactors cobalt and manganese for iron.
Numerous barriers stand between pathogens and the iron they require from the
host. In aqueous, aerobic environments, the primary state of iron is ferric hydroxide,
which has a solubility of 1.4 x 10-9 M at pH 7 (Schaible and Kaufmann 2004).
Additionally, although iron is required for life, free iron can catalyze the formation of
damaging reactive oxygen species via the Fenton reaction, which damage lipids,
proteins, and nucleic acids:
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H2O2 + Fe2+ ⇒ Fe3+ + OH- + OH·
(Wooldridge and Williams 1993; Van Ho and others 2002; Masse and Arguin 2005). In
order to minimize the catalysis of reactive oxygen species, mammals produce ironbinding proteins, including transferrin, that chelate iron in the blood; lactoferrin, that
binds iron in mucosal secretions; and ferritin, the primary intracellular iron storage
protein (Levenson and Tassabehji 2004; Oates and Ahmed 2007).
Control of iron level also plays a role in innate immunity, as iron availability is a
primary requirement for infection; general limitation of free iron helps to prevent
infection, and increased limitation occurs in response to infection (Kadner 2005;
Sritharan and others 2006; Markel and others 2007). For example, macrophages
express the protein ferroportin following activation in order to reduce intracellular iron;
ferroportin is the only cellular iron efflux protein in mammals and is also expressed in
enterocytes and hepatocytes (Ganz 2005).
Because iron availability is a primary limitation to infection, bacteria have evolved
numerous virulence factors in response to limited iron availability. Reduced iron
availability is known to induce toxin expression by pathogens, including the shiga toxin
in Shigella dysenteriae, the shiga-like toxin in E. coli, exotoxin A in Pseudomonas
aeruginosa, and diptheria toxin in Corynebacterium diptheriae (Litwin and Calderwood
1993; Hantke 2001). Additionally, pathogens posses numerous mechanisms to obtain
iron from host stores. Most pathogens express siderophores, compounds that directly
chelate iron from host iron-protein complexes with high affinity (KD value of 1022-1050).
Over 500 different siderophores have been identified and can originate from bacteria,
yeast, and fungi (Ratledge and Dover 2000); however, no homologs for enzymes
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responsible for siderophore synthesis have been identified in the C. trachomatis
genome (Stephens and others 1998).
Another bacterial scheme for obtaining iron is the expression of receptors for
host iron-containing compounds, such as human heme, hemoglobin, transferrin, and
lactoferrin. Receptors specific for transferrin have been identified in several pathogens,
including Neisseria meningitidis (Schryvers and Morris 1988), Pasteurella haemolytica
(Ogunnariwo and Schryvers 1990), Staphylococcus auerus (Modun and others 1994),
Moraxella catarrhalis (Campo and others 2004), and Borrelia burgdorferi (Carroll and
others 1996); acquisition of iron from transferrin has also been implicated in the iron
acquisition strategies of the obligate intracellular pathogens Coxiella (Howe and others
2005) and Ehrlichia (Barnewall and others 1997). Another iron acquisition strategy by
pathogens during intracellular growth involves accessing ferritin or heme, which has
been shown to be important for Neisseria meningitidis (Larson and others 2004),
Mycobacterium tuberculosis (Olakanmi and others 2002), and the intracellular fungus
Histoplasma capsulatum (Hwang and others 2008). Additionally, the intracellular
protozoan Leishmania appears to rely on the reduction of ferric to ferrous iron followed
by internalizing the solubilized iron via a ferrous iron transporter (Huynh and Andrews
2008).
While no gene homologues for proteins involved in conserved iron-uptake
mechanisms (i.e. siderophores or receptors for eukaryotic iron-binding proteins such as
transferrin) were identified following sequencing of the C. trachomatis serovar D
genome (Stephens and others 1998), it is likely that chlamydiae actively obtain iron from
the host due to the low concentration of soluble iron in the eukaryotic cell and the fact
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that the inclusion membrane is known to prohibit diffusion of tracer molecules as small
as 520 Da (Heinzen and Hackstadt 1997). Scidmore and Hackstadt showed that
incubation of infected cells with 55Fe-labeled human transferrin resulted in radiolabeled
EB, although at low levels (Scidmore and Hackstadt 1995), and Raulston demonstrated
that the addition of human transferrin to infected cells grown under iron-deficient
conditions restored the infectivity of EB (Raulston 1997). Interestingly, a recent report
has demonstrated that reduced expression of transferrin or Rab11, a protein involved in
trafficking of transferrin-positive vesicles, reduces the production of infectious EB
(Heuer and others 2006). These observations make it tempting to hypothesize
chlamydiae obtain iron from transferrin; however, while transferrin-positive vesicles
have been found adjacent to the chlamydial inclusion, researchers have been unable to
detect the transferrin-transferrin receptor complex in the inclusion membrane, either by
transmission electron microscopy (TEM; Scidmore and others 1996; Taraska and others
1996) or fluorescence microscopy (van Ooij and others 1997). The identification of a
chlamydial transferrin receptor would make a promising potential vaccine candidate;
numerous studies have investigated the use of the transferrin receptor as a vaccine
target for Neisseria meningitidis (Banerjee-Bhatnagar and Frasch 1990; Danve and
others 1993; Pintor and others 1996; Schryvers and Stojiljkovic 1999).
If iron-containing compounds were trafficked into the inclusion and bound to the
chlamydial outer membrane, chlamydiae would still need to transport the iron
compounds across both the outer and inner chlamydial membranes. The TonB-ExbBExbD system is a conserved complex that is required for transport of iron complexes
across the Gram-negative outer membrane into the periplasm, providing the energy
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required to move the iron compounds across the outer membrane and into the
periplasm, where the iron is extracted and moved into the cytoplasm (Larson and others
2002). Genes encoding accessory proteins involved in the TonB transport system were
identified in the chlamydial genome (tolB, tolQ, exbD), but no homologue was found for
TonB itself (Stephens and others 1998).
Although the iron acquisition pathway used by chlamydiae is undefined, a
homolog to the primary iron regulatory protein in Gram-negative bacteria, the
transcriptional repressor Fur, has been identified. Under elevated iron levels, activated
Fur binds to specific regions in the promoter region of regulated genes, termed Fur
boxes, preventing transcription of that gene; when iron levels are lowered, Fur becomes
deactivated and loses its association with DNA, allowing transcription of the regulated
gene to resume. The chlamydial Fur homolog, termed DcrA (divalent cation-dependent
regulator), has demonstrated the ability to bind E. coli Fur boxes (Wyllie and Raulston
2001). Binding of purified E. coli Fur protein to a chlamydial library has identified
several putative DcrA binding sites in the chlamydial genome (Rau and others 2005).
While genetic manipulation via gene knockout and directed mutation is the
standard method of investigating virulence genes, this approach is not currently feasible
in Chlamydia due to problems inherent in its biphasic, obligate intracellular lifestyle,
including difficulties in isolating discrete clonal colonies (Tam and others 1994). The
goal of the research detailed in this dissertation has been to further characterize the
chlamydial response to iron restriction at the molecular level. While analysis of
transcription can provide critical information regarding transcriptional regulation, we
chose to pursue the question of how chlamydiae respond to iron limitation through a
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primarily proteomic approach because protein expression represents the end-stage of
regulation. The first study (Chapter 2) examined expression of the three Hsp60
homologs following an iron restrictive shock to identify which homolog or homologs
were iron responsive. In the second study (Chapter 3), an established cell line capable
of inducible expression of the iron-exporting protein ferroportin was evaluated for its
potential use as a model for chlamydial iron restriction; this was examined via TEM,
infectivity of progeny EB, and host cell iron level. In the final study (Chapter 4),
chlamydial proteins demonstrated to be iron-responsive during intracellular growth were
identified, and the transcript levels encoding a subset of these proteins were measured
in the presense or absense of iron restriction over a timecourse of infection.
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CHAPTER 2

CHLAMYDIAL HSP60-2 IS IRON RESPONSIVE IN CHLAMYDIA TRACHOMATIS
SEROVAR E-INFECTED HUMAN ENDOMETRIAL EPITHELIAL CELLS IN VITRO

Richard W. LaRue1, Brian D. Dill1*, David K. Giles1, Judy D. Whittimore1, and Jane E.
Raulston1,2

Departments of Microbiology1 and Pathology2, James H. Quillen College of Medicine,
East Tennessee State University, Johnson City, Tennessee

*Corresponding author:
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PO Box 70579, Johnson City, TN 37614-1708.
Telephone: 423-439-6299
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Abstract

Chlamydial heat shock proteins 60kDa (cHsp60s) are known to play a prominent role
in the immunopathogenesis of disease. It is also known that several stress-inducing
growth conditions, such as heat, iron deprivation, or exposure to interferon-γ, result in
the development of persistent chlamydial forms that often exhibit enhanced expression
of cHsp60. We have shown previously that the expression of cHsp60 is greatly
enhanced in Chlamydia trachomatis serovar E propagated in an iron-deficient medium.
The objective of this work was to determine which single cHsp60 or combination of the
three cHsp60 homologs encoded by this organism responds to iron limitation. Using
monospecific polyclonal peptide antisera that recognize only cHsp60-1, cHsp60-2, or
cHsp60-3, we found that expression of cHsp60-2 is responsive to iron deprivation.
Overall, our studies suggest that the expression of cHsp60 homologs differs among the
mechanisms currently known to induce persistence.

Infection and Immunity 75 (5): 2374-80 (2007)
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Introduction
Studies have consistently shown that there is a correlation between the production of
chlamydial 60-kDa heat shock protein (cHsp60) antibodies in chlamydiae-infected
patients and adverse disease consequences. These observations appear to be
universal for Chlamydia species and their disease presentations. Early studies of
whether cHsp60 plays a role in immunopathogenesis involved analyses of serum
antibodies from female patients presenting with Chlamydia trachomatis-associated tubal
infertility (7, 52); elevated levels of anti-cHsp60 in the sera of these patients were
significantly associated with disease. A separate group of investigators described the
contribution of cHsp60 in a guinea pig model of trachoma; an intense mononuclear cell
inflammatory response was observed after conjunctival inoculation of cHsp60 following
resolution of a primary ocular infection with Chlamydia psittaci GPIC (37). Patients with
coronary artery disease often have serological evidence of previous infection by
Chlamydia pneumoniae (45), and cHsp60 has been directly identified in human
atheromatous tissue (31). Most recently, C. pneumoniae and Chlamydia pecorum
cHsp60s have been implicated in urogenital tract disease in koalas (Phascolarctos
cinereus), leading to infertility and death; chlamydiae are the most commonly
recognized disease agents in the threatened koala population (23, 24).
Studies to determine the role of cHsp60 and immunopathogenesis are still being
performed. Recently, workers have examined the initial interactions of cHsp60 with
host cells that induce an inflammatory response. For example, cHsp60 interacts with
Toll-like receptor 4 that stimulates the proliferation of human vascular smooth muscle
cells (47), activates macrophages, and activates endothelial cells (8). The interaction
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between cHsp60 and Toll-like receptor 4 also leads to apoptosis in primary human
trophoblasts, placental fibroblasts, and a trophoblast cell line by both caspasedependent and -independent pathways (18). cHsp60 and other microbial ligands can
also activate mononuclear cells by binding to CD14, the monocyte receptor for
lipopolysacharide (32). Although cHsp60 clearly plays a prominent role in chlamydial
pathogenesis, it is not the only molecule involved. The genetically linked cHsp10,
encoded by the groES gene upstream of groEL-1, is also associated with disease
complications (6, 23, 27, 33). Moreover, several studies have demonstrated that
genetic predisposition plays a significant role in chronic chlamydial disease (10, 12, 38).
Perhaps most interesting is the fact that cHsp60 has been used in a human trial
involving women at high risk for C. trachomatis infection; cHsp60 was used to stimulate
the patients’ peripheral blood mononuclear cells to produce gamma interferon (IFN-γ),
and the results indicated that a protective response against incidental infection
developed (11).
Our laboratory is involved in identifying and analyzing C. trachomatis proteins that
respond to iron restriction, as well as the mechanisms involved (42, 43, 55); cHsp60 is
one of several proteins whose expression increases significantly during iron limitation in
vitro (43). It is known that iron sources and the availability of iron fluctuate in
menstruating women due to the cyclic pressures of estrogen and progesterone (1, 29);
active or persistent C. trachomatis organisms in the reproductive tract are therefore
likely to respond to this dynamic environment using transcriptional, translational, or
posttranslational mechanisms to alter the production of specific chlamydial proteins.
While we are not involved in direct studies of persistent chlamydiae, which have been
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defined as viable but non-culturable organisms (3), iron deprivation is one of several
modes for induction of persistent chlamydiae (22, 39, 43). In women with tubal factor
subfertility, cHsp60 is a serological marker for persistence (15) along with chlamydial
proteasome/protease-like activity factor (48). However, the result of recent studies with
C. psittaci (22) and C. pneumoniae (39) indicate that cHsp60 is not a general marker for
persistence.
When the complete sequence of the C. trachomatis serovar D chromosome became
available, one of many surprises was that there are three open reading frames (ORF)
that code for groEL-related proteins (49). These ORF are positioned in separate
regions of the chromosome and designated as follows: CT110 or groEL-1, encoding
cHsp60-1; CT604 or groEL-2, encoding cHsp60-2; and CT755 or groEL-3, encoding
cHsp60-3. Only groEL-1 is preceded by groES. Matching cHsp60s in different
Chlamydia species appears to be conserved in the sequences that are currently
available. For example, the predicted level of amino acid sequence identity between
cHsp60-1 in C. trachomatis serovar D and cHsp60-1 in C. pneumoniae AR39 is 91%.
However, there are considerable differences between cHsp60-1, cHsp60-2, and
cHsp60-3 in a given species or serovariant. In C. trachomatis serovar D, the levels of
amino acid identity and similarity between cHsp60-1 and cHsp60-2 are 23% and 19%,
respectively; the levels of amino acid identity and similarity between cHsp60-1 and
cHsp60-3 are 18% and 20%, respectively; and the levels of amino acid identity and
similarity between cHsp60-2 and cHsp60-3 are 17% and 15%, respectively (28, 35, 49).
Although the majority of previous studies clearly involved cHsp60-1, as confirmed by
sequence analysis, certain studies, including our study (43), generated new questions
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concerning the extent to which each cHsp60 responds to a given microenvironment,
especially a microenvironment leading to chlamydial persistence. Thus, the purpose of
this study was to determine which cHsp60 is iron responsive in C. trachomatis serovar
E.

Materials and methods
Bacterial strains, eukaryotic host cells, and growth
Stock inocula of C. trachomatis serovar E/UW-5CX EB were generated in McCoy
cell fibroblasts and titrated to determine their infectivity. Polarized human endometrial
epithelial cells (HEC-1B) were used as host cells in iron deprivation experiments and
were maintained in Eagle’s minimal essential medium containing 2 mM glutamine and
5% (vol/vol) heat-inactivated fetal bovine serum at 37°C. For induction of iron
deprivation, chlamydiae-infected cultures were allowed to grow to 36 hrs postinoculation (hpi) and one-half of the samples were exposed to 500 µM Desferal for 30
min and 1 hr and 2 hrs.
Escherichia coli LMG194 (pBAD/HisA) was used to engineer and overexpress each
cHsp60. The recombinants expressing cHsp60-1, cHsp60-2, and cHsp60-3 were
designated as E. coli LMG194 (pJER516), E. coli LMG194 (pJER517), and E. coli
LMG194 (pJER518), respectively. Each recombinant E. coli was grown in reduced
medium (Invitrogen, Carlsbad, CA) containing 0.2% (wt/vol) glucose and 100 µg/ml
ampicillin (Sigma Genosys, The Woodlands, TX) to the mid-log phase (A600, 0.4 to 0.6)
at 37°C. Cultures were subsequently centrifuged, washed, and resuspended in
prewarmed glucose-free medium. Arabinose was then added to each culture for 4 h of
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induction. Maximum expression of cHsp60-1and cHsp60-2 in E. coli LMG194
(pJER516) and E. coli LMG194 (pJER517) required 0.002% (wt/vol) arabinose,
whereas maximum expression of cHsp60-3 in E. coli LMG194 (pJER518) required 20%
(wt/vol) arabinose.

DNA amplification, cloning, and sequence analysis
The primers used for the PCR amplification of the chlamydial groEL genes were
designed using the genome sequence of C. trachomatis serovar D (49). The reactions
were carried out with an Expand High Fidelity PCR system kit (Roche, Nutley, NJ) in the
presence of 0.5 pmol of forward, 0.5 pmol of reverse primer, and 10-fold (1:10-1:1,000)
dilutions of C. trachomatis serovar E DNA template. After 35 cycles of amplification, the
PCR products were cleaned-up using a QIAquick PCR purification kit (Qiagen,
Germantown, MD); the sizes and concentrations of the purified products were
monitored by agarose gel electrophoresis in the presence of ethidium bromide and by
determining the optical density, respectively. All PCRs were done in duplicate to reduce
introduction of errant nucleotides. The PCR products were then directionally cloned into
the pBAD/HisA vector (Invitrogen, Carlsbad, CA) under the control of the araC promoter
with a N-terminal six-histidine tag for recombinant protein detection and used to
transform E. coli LMG194 by the traditional CaCl2 method (46). For each groEL gene,
the recombinant plasmids from three clones were purified using the Concert nucleic
acid purification kit (Invitrogen) and then sequenced to verify in-frame cloning and to
determine the complete nucleic acid sequences.
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Peptide antibodies
The predictive amino acid sequences of C. trachomatis serovar E Hsp60-1,
Hsp60-2, and Hsp60-3 were aligned using the EditSeq and MegAlign software from
DNAStar, Inc. (Madison, WI). Peptides that were 17 to 21 residues long, detailed by
Giles et al. (21), were commercially synthesized, the purity was assessed by analytical
high-pressure liquid chromatography and mass spectroscopy, and each peptide was
subsequently used to immunize two female New Zealand White rabbits (SigmaGenosys, The Woodlands, TX). The results of enzyme-linked immunosorbent assays
were provided by the manufacturer to ensure reactivity.
The majority of antiserum from each bleed was immediately stored at -20°C upon
receipt. One milliliter of antiserum from each bleed was kept at 4°C to determine the
Western blot reactivities of the crude preimmune and immune sera against total protein
from HEC-1B cells and E. coli LMG194 as controls and arabinose-induced recombinant
E. coli LMG194 (pJER516), E. coli LMG194 (pJER517), and E. coli LMG194
(pJER518). Immune sera exhibiting the most selective reactivity with the intended
Hsp60 homolog were then placed on protein A columns (ImmunoPure immobilized
protein A, Pierce, Rockford, IL) to purify immunoglobulin G, and Western blotting was
performed to determine the degree of monospecificity and the reduction in the crossreactivity with other E. coli proteins. Antiserum against the peptide from cHsp60-3
required a further step of adsorption against whole cells of arabinose-induced E. coli
LMG194 (pJER516) expressing cHsp60-1. A monoclonal antibody reagent (SigmaGenosys, The Woodlands, TX) against the polyhistidine tag was also used in this study.
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Protein quantitation, sodium dodecyl sulfate-polyacrilamide gel electrophoresis,
Western blotting, and chemiluminescence
The total protein concentrations of samples were determined using the Micro
BCA Assay (Pierce, Rockford, IL). Cell pellets were resuspended in lysis buffer (10 mM
Tris-HCl, 1 mM EDTA, 0.5 mg/ml lysozyme, 0.1 mg/ml DNase I, and 10 mM CaCl2) and
subjected to three freeze-thaw cycles. After the final thaw, samples were centrifuged at
8,000 X g for 10 min, and each supernatant was combined with denaturing sample
buffer and heated at 100°C for 5 min. The proteins were resolved in small-format 412% Bis-Tris NuPAGE gels (Invitrogen, Carlsbad, CA) and transferred to nitrocellulose
membranes for Western blotting. Preliminary separations were conducted in largeformat 12.5% polyacrylamide gels loaded with 1 mg of protein to accommodate multiple
blots for screening and titrating antisera.
For Western blotting, membranes were blocked with Blotto-plus (5% [wt/vol] dry nonfat milk in phosphate-buffered saline, 0.1% [vol/vol] Tween 20, and 10% [vol/vol] heatinactivated fetal bovine serum), and washing was performed with phosphate-buffered
saline containing 0.1% (vol/vol) Tween 20. Various dilutions were examined for the
polyclonal peptide antisera generated against each of the cHsp60s, and a monoclonal
antibody against the poly-His tag (Sigma-Genosys, The Woodlands, TX) was also used
as a control. Specific signals were then detected either (i) by a colorimetric assay with
an anti-rabbit alkaline phosphatase-conjugated secondary antibody and Western Blue
substrate (Promega, Madison, WI), or (ii) by chemiluminescence using an anti-rabbit
horseradish peroxidase conjugate, the SuperSignal West (Pierce) solution, and Kodak
X-OMAT AR film.
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Electron microscopy
Samples of C. trachomatis-infected polarized HEC-1B cells at 36 hpi were
exposed to 500µM Desferal for 30 min and 1 h and 2 h; mock-exposed samples were
used as controls. Each sample was immediately washed, fixed, processed, and
embedded in Epon-araldite and Lowicryl (Polysciences, Inc.) for high-contrast electron
microscopy and immunoelectron microscopy, respectively, as described by Giles et al.
(21).
Visualization and image capture were done using a Philips Tecnai 10
transmission electron microscope (FEI Company, Hillsboro, Oregon) operating at 80 kV.

Nucleotide sequence accession numbers
The sequences determined in this study have been deposited in the GenBank
database under the following accession numbers: AY447001 for C. trachomatis serovar
E groEL-1, AY447002 for C. trachomatis serovar E groEL-2, and AY447003 for C.
trachomatis serovar E groEL-3.

Results
Amplification and nucleotide sequence analysis of C. trachomatis serovar E groEL ORF
DNA that was the expected size was amplified with all dilutions of the C.
trachomatis serovar E groEL DNA templates except the groEL-3/CT755 template (Fig.
2.1A, lanes 3). Figures 2.1B and 2.1C show the results of a change in primer strategy,
and the data revealed that CT755 was present along with the flanking sequences.
Further analysis showed that a missing cytosine residue in the initial sequence of the
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CT755 in serovar E at position 25 was responsible for the lack of primer hybridization
and amplification (Fig. 2.1D). As determined by comparison with the published
sequence of CT755 in serovar D, a frameshift placed the ORF back into frame by
insertion of a cytosine residue at position 30 in serovar E. The final results were
confirmed using a new set of primers (Figure 2.1E). The nucleotide sequences of C.
trachomatis serovar E groEL-1, groEL-2, and groEL-3 are 99.7%, 98.5%, and 99.2%
identical to their counterparts in C. trachomatis serovar D, with only 6-, 25-, and 8-bp
differences, respectively.
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Figure 2.1 PCR amplification of C. trachomatis serovar E groEL. (A) Initial attempt to
amplify groEL-1, groEL-2, and groEL-3 (lanes 1, lanes 2, and lanes 3, respectively) from
C. trachomatis serovar E DNA template and primers based on the sequence of C.
trachomatis serovar D. (B) Strategy used to amplify groEL-3 and flanking sequences.
(C) Result of amplification of groEL-3 and flanking sequences. Lanes 1 through 5
contained areas indicated in panel B, and amplification of groEL-1 was used as a
control. (D) Difference in the starting sequences of C. trachomatis serovars D and E.
(E) Amplification of C. trachomatis serovar E groEL-1, groEL-2, and groEL-3 with
redesigned primers for groEL-3.

Specificity of the peptide antisera
Monospecificity was achieved for anti-cHsp60-1 and anti-cHsp60-2 with
purification of immunoglobulin G alone (Fig. 2.2A). Antiserum against cHsp60-3 initially
exhibited faint cross-reactivity with Hsp60-1 that was removed by cross-adsorption
against whole cells of arabinose-induced E. coli LMG194 (pJER516) expressing
cHsp60-1. A control using an anti-histidine monoclonal antibody (Sigma-Genosys, The
Woodlands, TX) was included.
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Iron-responsiveness of cHsp60s
Next, the peptide antibodies were used to examine C. trachomatis-infected cells
with or without 500 µM Desferal, which were exposed for 30 min and 1 h and 2 h,
beginning at 36 hpi (Fig. 2.2B). Preliminary experiments using the standard 50 µM
Desferal for 96 h resulted in induction of a persistence-like state (43); these initial
experiments indicated that only cHsp60-2 responds to iron deprivation beginning at 36
hpi (data not shown). Therefore, we changed the strategy in a manner analogous to
application of heat, cold, or acid shock in other bacteria. Figure 2.2B confirms that
cHsp60-2 is the primary cHsp60 that responds to iron limitation. Notably, cHsp60-2 is a
target of proteolysis during cell lysis even in the presence of protease inhibitors (several
combinations of inhibitors were tested). The data also showed that cHsp-1 is strongly
expressed, but there was little or no difference between the expression in the absence
of Desferal and the expression in the presence of Desferal; cHsp60-3 expression was
delayed, but again, there was little difference between expression in the absence of
Desferal and the expression in the presence of Desferal.
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Figure 2.2 Specificity of peptide antisera and response of cHsp60-2 to iron deprivation.
(A) Samples used for Western blotting included uninfected HEC-1B cells, E. coli
LMG194 alone, and arabinose-induced recombinants E. coli LMG194 (pJER516), E.
coli LMG194 (pJER517), and E. coli LMG194, representing cHsp60-1, cHsp60-2, and
cHsp60-3, respectively. An anti-His tag monoclonal was used as a control (upper left
panel). (B) Samples included uninfected HEC-1B cells (control) (lanes C), cells mock
exposed for 30 min and 1 h and 2 h, and cells exposed to Desferal for 30 min and 1 h
and 2h. One milligram of protein was loaded onto preparative gels (A), whereas 15 µg
was loaded into each lane in panel B. Arrowheads indicate the position of cHsp60. The
asterisk indicates the position of a major proteolytic product of cHsp60-2, and the circle
indicates the position of a cross-reactive protein in HEC-1B cells.
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Immunoelectron microscopy
To confirm that C. trachomatis cHsp60-2 is iron responsive, the final experiment
involved examination of thin sections by immunoelectron microscopy. Multiple images
were captured, saved as TIFF files, and printed; 2 µm square grids were used to
enclose 10 to 15 randomly selected squares containing chlamydial reticulate bodies
(RB) on prints of each sample, and the gold particles in each box were counted (Fig.
2.3).
Figure 2.3A, C, and E represent chlamydial RB in HEC-1B cells at 36 hpi (mock
exposure); Figure 2.3B, D, and F illustrate RB at 36 hpi in cells that were exposed to
500µM Desferal for 1 h. Consistent with the results of the Western blot analyses,
cHsp60-1 was strongly expressed, but there was not a significant difference between
mock-exposed chlamydiae and chlamydiae exposed to Desferal (Fig. 2.3A and B); the
number of particles in Figure 2.3A and B for cHsp60-1 were 19 (+/- 8) and 18(+/- 6),
respectively. Likewise, for weakly expressed cHsp60-3 there was no difference
between mock exposure and exposure to Desferal; the numbers of gold particles in both
Fig. 2.3E and F were 5 (+/- 2). However, there was a significant difference (P < 0.001)
between expression of cHsp60-2 between mock exposure and exposure to Desferal
(Fig. 2.3C and D), as determined by Student’s two-tailed t test; the numbers of gold
particles in Fig. 2.3C and D were 4 (+/- 2) and 10 (+/- 3), respectively.
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Figure 2.3 Immunolabeling transmission electron microscopy showing the response of
cHsp60-2 to iron limitation. Chlamydia-infected HEC-1B cells at 36 hpi were either not
exposed to Desferal (A, C, and E) or exposed to 500µM Desferal (B, D, and F) for 1 h
and labeled using a 1:100 (vol/vol) dilution of anti-cHsp60-1 (A and B), a 1:20 (vol/vol)
dilution of anti-cHsp60-2 (C and D), or a 1:40 (vol/vol) dilution of anti-cHsp60-3 (E and
F). A 15nm gold-conjugated anti-rabbit serum (Amersham Biosciences) was used at a
1:200 (vol/vol) dilution for visualization. Bars = 0.5 µm. The arrowheads indicate gold
particles.
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Discussion
In this report we show conclusively that C. trachomatis serovar E Hsp60-2 is the
primary cHsp60 that exhibits enhanced expression in response to iron restriction. In a
larger context, the specificity of cHsp60-2 expression as a result of iron limitation
indicates that the mechanisms for development of chlamydial persistence have unique
signatures. This is an emerging concept in the study of chlamydial pathogenesis. The
expression of cHsp60s, as determined by either protein expression or transcript
analysis, has been examined in several models of persistence (2, 4, 17, 19, 22, 39).
Belland and colleagues (4) conducted a comprehensive microarray study of C.
trachomatis serovar D transcription and compared standard growth and growth of IFN-γmediated persistent chlamydiae in HeLa 229 cells. None of the groEL transcripts varied
significantly for the first 24 h; however, by 48 hpi, transcription of groEL-1 increased 2.8fold due to tryptophan depletion by IFN-γ. Tryptophan is an essential amino acid for C.
trachomatis. A separate group of investigators examined transcription using
quantitative real-time PCR for three distinct modes of persistence, exposure to IFN-γ,
penicillin G, and iron depletion, in C. psittaci growing in HEp-2 cells (22). At 24 hpi,
groEL-1 was upregulated only in the penicillin G model of persistence; IFN-γ persistence
actually showed a significant downregulation of groEL-1. Downregulation of groEL-1
was also observed for 48 hpi for C. psittaci persistence induced by iron deprivation;
groEL-2 was not examined in this study. Using a different stress environment,
Karunakaran and colleagues (28) examined transcription using a heat shock model.
HeLa 229 cells were infected with C. trachomatis serovar D for 18 h and subsequently
subjected to a 10-min heat pulse at 45°C. mRNA was quantified using a microarray

41

procedure, and the results showed that there was a >5-fold increase in groEL-1
transcripts; the quantities of the groEL-2 and groEL-3 transcripts did not change. In
studies of protein expression, expression of C. trachomatis serovar A cHsp60-1, as
determined using Western blotting and an anti-cHsp60-1 monoclonal antibody, was
enhanced in an in vitro model of IFN-γ-mediated persistence (2). For C. pneumoniae
cHsp60-1, there was a twofold increase in expression at 48 hpi with the following three
different models of persistence and/or stress: (i) IFN-γ exposure, (ii) iron deprivation,
and (iii) heat shock (39).
Our findings are more consistent with results reported by Gerard and colleagues
(20). These investigators quantified mRNA for each groEL homolog in C. trachomatis
serovar K using real-time reverse transcription-PCR with the following systems: (i)
active infection in HEp-2 cells, (ii) persistent infection in human monocytes, and (iii)
synovial tissue from patients with Chlamydia-associated arthritis. In active HEp-2 cell
infection, all groEL transcripts were present beginning at 8 hpi, and the levels increased
throughout chlamydial development; groEL-3 was transcribed at the highest levels. In
the monocyte persistence model, the levels of groEL-1 and groEL-3 transcripts were
low, whereas the level of the groEL-2 transcripts increased threefold over 3 days as the
organisms entered the persistent state. Findings for the synovial tissues also showed
that the levels of groEL-2 transcripts were high. Comparisons with this model of C.
trachomatis serovar K persistence in monocytes may not be entirely legitimate because
our model involves C. trachomatis serovar E, a less invasive organism, in epithelial
cells, but the observations are intriguing nonetheless.

42

From the standpoint of immunopathogenesis, the importance of cHsp60s in disease
has been the subject of several excellent reviews (9, 13, 14, 16, 26, 30, 34, 40). Our
previous work, performed with the antisera generated in this study, showed that
cHsp60-2 and cHsp60-3 but not cHsp60-1 escape from chlamydial inclusions via
vesicle eversion, a process that is exacerbated by exposure to azithromycin (21, 44).
The vesicles are thought to interact with host cell antigen presentation and to contribute
to the inflammatory response. Studies of heat shock proteins, in general, are being
performed because heat shock proteins carry antigens and deliver peptides to the major
histocompatibility complex, thus priming the adaptive immune response by inducing
specific B and T cells in the absence of adjuvants (41). Heat shock proteins also
participate in the innate immune response by stimulating the production of chemokines
(41). In one study, cHsp60 serum antibodies were shown to serve to be the best
predicting factor for tubal factor infertility (51). Mapping of cHsp60-1 peptide epitopes in
human sera has been done (50, 54); it may be worthwhile to investigate whether
peptides of cHsp60-2 and/or cHsp-3 contribute to the generation of specific
immunoglobulins.
GroEL proteins are essential for bacterial growth and ensure that newly synthesized
proteins are functional; expression of GroEL proteins increase in response to a variety
of stresses, including heat shock and nutrient deprivation (56). Structural studies of
cHsp60s have shown that although the primary amino acid sequences of cHsp60s differ
from the primary amino acid sequences of other organisms, amino acid residues
involved in binding polypeptides are conserved (28). It is also clear that cHsp60-1 is
negatively regulated by the interaction of a negative regulator, HcrA, with a CIRCE
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element in the operator regions of the groES-groEL-1 and dnaK operons; HrcA does
not appear to regulate groEL-2 or groEL-3 (53). Although the results of studies of C.
trachomatis serovar K persistence and synovial fluid support the hypothesis that there is
regulation of chlamydial groEL-2 at the level of transcription, there appears to be no
Fur/DcrA binding site in upstream sequences. There is only a partial Fur box
approximately 300 bp downstream in C. trachomatis serovar E groEL-2; determining
whether DcrA binds to groEL-2 sequences is part of a separate project in our laboratory.
A likely alternative mechanism for enhanced expression of cHsp60-2 may involve small
RNAs that regulate genes posttranscriptionally or by stabilization of mRNA; numerous
iron-responsive proteins in other bacteria are known to be regulated in this fashion (25).
Chlamydiae code for several small RNAs (5). Finally, the increased level of cHsp60-2
might also involve protein stability. For example, when E. coli GroEL is bound to an
unfolded substrate in vitro, the complex remains stable at 25°C for more than 2 weeks;
at 43°C, the half-life is 1.5 h (36).
Overall, the results of this study and our previous work (21, 43) strongly indicate that
cHsp60-2 should be considered a potential mediator of immune-mediated damage, and
they mechanistically indicate that not all modes of chlamydial persistence are identical.
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Abstract

The obligate intracellular bacterium Chlamydia trachomatis requires iron in order
to complete its developmental cycle. Addition of an iron-chelating drug, Desferal
(deferoxamine mesylate), to infected cell culture causes Chlamydia to enter
persistence. Here, we explore the ability of a stably-transfected cell line with inducible
over-expression of the eukaryotic iron efflux protein ferroportin to starve C. trachomatis
serovar E for iron. Ferroportin-induced iron removal is perhaps a more direct method of
removing iron from the intracellular compartment versus exposure to an exogenous
chemical chelator. Following induction, ferroportin-green fluorescent protein (Fpn-GFP)
was detected in the plasma membrane, and cells expressing Fpn-GFP remained viable
throughout the timescale required for Chlamydia to complete its developmental cycle.
Following Fpn-GFP induction in infected cells, chlamydial infectivity remained
unchanged, indicating chlamydiae were not in persistence. Ferritin levels indicate only
a small decrease in cellular iron following Fpn-GFP expression relative to cultures
exposed to Desferal. These data indicate that expression of Fpn-GFP in chlamydiaeinfected cells is not capable of reducing iron below the threshold concentration needed
to cause chlamydiae to enter persistence.
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Introduction
Chlamydia trachomatis serovar E, an obligate intracellular bacterium, is the
leading cause of bacterial sexually transmitted disease in the United States. C.
trachomatis causes chronic, often asymptomatic infections, and can lead to more
serious sequelae including endometritis and pelvic inflammatory disease.
Members of the genus Chlamydia (and the reclassified Chlamydophila) exhibit a
unique biphasic developmental cycle, switching between the intracellular, replicative
reticulate body (RB) and the extracellular, metabolically inert elementary body (EB).
The canonical developmental cycle is interrupted when chlamydiae enter persistence.
While the formulation of a firm molecular definition is ongoing, chlamydial persistence is
characterized by a non-culturable, but viable, state in which RB do not undergo
maturation into EB. Cellular division ceases, RB become enlarged, and transcription
and protein expression profiles are altered. Several inducers of persistence have been
observed, the most studied being tryptophan deprivation via interferon-γ exposure and
incubation in the presence of penicillin. Persistence is a phenomenon of medical
importance because persistent chlamydiae are refractory to antibiotics and may
upregulate destructive virulence factors.
Iron starvation has been observed to induce persistence in chlamydiae. Upon
depletion of intracellular iron stores with the iron-chelating drug Desferal (deferoxamine
mesylate), chlamydiae demonstrate delayed development, decreased infectivity of
progeny EB, and the appearance of enlarged RB, which is reversible upon
supplementing the medium with an iron source [1-4]. The existence of an irondependent repressor [5,6] and differential transcription and protein expression profiles
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[3,4,7,8] further illustrate the requirement for Chlamydia for iron.
The reliance of chlamydiae on iron availability is not surprising, as iron is the
most important metal in biological systems and is required by nearly all organisms
studied. This ubiquitous reliance of life on iron has evolved because the chemical
properties of iron allow it to function as a biocatalyst and electron carrier when
incorporated into proteins. While life depends on iron, iron in an aerobic environment
poses some difficulties. Ferric iron (the form predominating in an aerobic environment)
has a solubility of only 10-18 M at pH 7.0, and free iron can generate damaging free
radicals via the Fenton reaction [9]. Thus, organisms tightly sequester iron with highaffinity binding proteins. Major iron-binding proteins in mammals include transferrin,
lactoferrin, heme, and ferritin.
Because free iron is so scarce in the host, iron availability is a primary limitation
to bacterial colonization, and many pathogens possess virulence factors regulated by
iron availability, including siderophores, receptors for iron-binding proteins, iron
transporters, and exotoxins [10,11].
It is clear that iron availability fluctuates in the endometrium of menstruating
women [12-15] and, thus, chlamydiae inhabiting this environment experience a
modulation in iron availability. The importance of characterizing iron-restricted
chlamydiae lies not only in elucidating mechanisms with which chlamydiae acquire iron
from within its intracellular environment but also in identification of iron deprivationassociated virulence factors involved in chlamydial pathogenesis.
Although Desferal creates an iron-restricted environment for chlamydiae, addition
of an exogenous chemical may have pleiotropic effects on the host cell. In order to use
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a more elegant and direct system for starving chlamydiae for iron, we explored the use
of a cell line with inducible iron starvation via over-expression of the eukaryotic iron
efflux protein ferroportin. Ferroportin (IREG1, MTP, Slc 11a3) is the major iron exporter
of enterocytes, macrophages, and hepatocytes and functions to secrete intracellular
iron into the bloodstream [16,17]. With the idea that cells over-expressing ferroportin
could be used in chlamydial iron studies, we obtained a stably-transfected cell line with
an inducible gene expressing a ferroportin-green fluorescent protein fusion (Fpn-GFP).
This cell line was capable of generating a drop in intracellular iron level following
induction of Fpn-GFP, measured by a decrease in ferritin, the major intracellular iron
storage protein [18].

Materials and Methods
Cell culture
Human Embryonic Kidney cells (HEK293) and a stably transfected cell line
expressing a ferroportin-green fluorescent protein fusion (HEK293-Fpn-GFP) were used
to examine the effect of Fpn-GFP expression on chlamydial infectivity. In brief, the
HEK293-Fpn-GFP cell line has two introduced elements: a stably expressed ecdysone
receptor and an ecdysone inducible promoter upstream of the recombinant ferroportin
gene fused with a GFP tag. The ecdysone analog, ponasterone A, is used to induce
expression of Fpn-GFP.
HEK293 cells were maintained in Dulbecco’s Modified Essential Medium (DMEM) supplemented with 10% (vol/vol) Fetal Bovine Serum (FBS), 2 mM GlutaMax
(Gibco), 1 µg/ml ciprofloxacin, 100 units/ml penicillin, and 0.1 mg/ml streptomycin.
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Medium for HEK293-Fpn-GFP cells is formulated as above, along with 0.4 mg/ml
Zeocin (Invitrogen) and 1 mg/ml G418. Media supplemented with 10 µg/ml ponasterone
A (A.G. Scientific, San Diego, CA) was used for induction of Fpn-GFP expression.
HEK293, HEK293-Fpn-GFP, and C. trachomatis innoculum were confirmed to be free
from Mycoplasma contamination by the VenorGem PCR test (Sigma-Aldrich).

Fluorescence microscopy
HEK293 and HEK293-Fpn-GFP cells were grown to subconfluency on 6-well
Costar Transwell filter insert plates (Corning), and medium was replaced with medium
plus or minus ponasterone. After 12, 24, or 36 hours (h), filter inserts were washed, cut
out, and fixed with fresh 4% (wt/vol) paraformaldehyde for 30 minutes. After washing,
filters were mounted on glass slides with Fluoromount-G (Southern Biotech,
Birmingham, AL). A FITC band pass filter was used to visualize GFP fluorescence on a
Zeiss Axiovert S 100 microscope. Images were captured with a Zeiss AxioCam digital
camera using AxioCam software v1.1.6. Identical exposure settings were used for all
images (exposure time=1 second, contrast=3, resolution=1280x1024).

Live/dead cell viability assay
Eukaryotic cell death was measured via the LIVE/DEAD Viability/Cytotoxicity Kit
(Molecular Probes) at 12, 24, and 36 h following addition of ponasterone A. Controls
included HEK293 cells without ponasterone. Host cells were grown in duplicate on
Costar filters and processed according to the protocol. The previously described
fluorescence microscope, camera, and capture software were used with a FITC long
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pass filter. The percentage dead cells of the total cells was determined by counting six
fields per filter.

Chlamydial infectivity
Cultures of HEK293 and HEK293-Fpn-GFP cells were grown in triplicate in 25
cm2 tissue culture flasks (Corning). All antibiotics were removed 24 h prior to infection.
C. trachomatis serovar E/UW-5/CX was used in all infections. The host cells were
infected with C. trachomatis inoculum titrated to infect 80% of cells and were
subsequently exposed to ponasterone at 36 hours post-infection (hpi). Controls
consisted of chlamydiae-infected cells incubated in medium without ponasterone A. EB
were harvested at 64 hpi, and were diluted 1:10 and used to infect fresh host cells
grown on glass coverslips. Six fields per replicate were counted to calculate percent
infectivity.

TEM analysis of chlamydial morphology
Samples were collected for thin-section transmission electron microscopy (TEM).
Host cells were infected as above and immediately exposed to medium with or without
ponasterone (HEK293-Fpn-GFP cells) or with or without 50 µM Desferal (HEK293
cells). At 48 hpi, cells were processed and embedded in Epon-Araldite 812 resin
(Polysciences, Inc.) as described previously [19]. Gold thin sections were cut on an
Ultracut T Microtome (Leica) and examined using a Tecnai 10 (FEI) transmission
electron microscope operating at 60-80 kV.
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Ferritin assay
The Spectro Ferritin Assay (Ramco Laboratories, Stafford, TX), an enzyme
immunoassay procedure, was used to measure ferritin content of samples. HEK293Fpn-GFP cells were incubated in flasks with medium with or without ponasterone A for
48 hours, and HEK293 cells were incubated in medium with 0, 5, 10, 25, or 50 µM
Desferal (Sigma-Aldrich) for 48 hours. Following incubation, cell monolayers were
washed three times in Dulbecco’s PBS and collected in lysis buffer (150 mM NaCl, 10
mM Tris [pH 7.4], 1% (vol/vol) Triton X-100, and a general protease inhibitor cocktail
[Sigma-Aldrich]). Ten to 20 µg of protein was loaded into each well, in triplicate, in 96well plates. The protein concentration of samples was determined by BCA assay
(Pierce) and was used to standardize ferritin concentrations for variations in protein
load. The entire experiment was repeated three times, with at least three replicates per
run. A two-tailed Student’s t-test was used to determine significance for a change in
ferritin concentration.

Results
Timeframe for Fpn-GFP expression
In order to coordinate Fpn-GFP expression with the chlamydial developmental
cycle, it was necessary to establish the timecourse of Fpn-GFP expression in
transfected HEK293 cells following addition of the inducer, ponasterone A.
Fluorescence microscopy was used to detect the green fluorescence of Fpn-GFP
following induction. Fluorescence was clearly visible beginning 12 hours following
induction, reached a maximum at 24 hours, and was stable through 36 hours (Fig. 3.1).
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Green fluorescence was also visible in the plasma membrane of the transfected cells,
the correct final location of this protein. Addition of ponasterone A to the HEK293 cell
line showed only background fluorescence similar to uninduced cells.

Figure 3.1 Fpn-GFP expression is visible by green fluorescence at the plasma
membrane of induced HEK293-Fpn-GFP cells. HEK293-Fpn-GFP (A, B) and
untransfected HEK293 (C, D) cells were incubated in medium containing the inducer
ponasterone A for 12, 24, and 36 hours, along with a negative control lacking
ponasterone A. Images were taken with fluorescence (A, C) and light (B, D)
microscopy. Bar = 50 µm.
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Host cell viability
The effect of Fpn-GFP expression on cell viability was unknown, and because
healthy host cells are an obvious necessity for chlamydial development, cell viability for
the remainder of the chlamydial developmental cycle following induction with
ponasterone A needed to be verified. Incubation of either the HEK293 or the HEK293Fpn-GFP cell lines with ponasterone A through 36 hours had no effect on viability (Fig.
3.2). The HEK293 cell population had an average of 6.5% dead cells (standard
deviation [s.d.] 2.9) across all incubation times, while the HEK293-Fpn-GFP had an
average of 28.5% dead cells (s.d. 5.4). Because the data showed there is no increase
in cell death as a result of Fpn-GFP expression, this rules out the possibility that
differences in infectivity after induction could be the result of host cell death.

Figure 3.2 Cell death following addition of ponasterone A as a function of time. HEK293
and HEK293-Fpn-GFP were incubated with 10 µg/ml ponasterone A for 12, 24, or 36
hours or in the absense of inducer. Cell death was calculated as a percentage of dead
cells to total cells measured using a live/dead assay.
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Infectivity of progeny EB harvested from induced versus uninduced cells
Decreased infectivity is a hallmark of chlamydial iron restriction. In order to
evaluate the ability of Fpn-GFP expression to starve chlamydiae for iron, an infectivity
assay was conducted to detect a change in infectivity in EB harvested from induced
cells versus uninduced cells. Because iron restriction interrupts the normal chlamydial
developmental cycle, it was hypothesized that a Fpn-GFP-mediated drop in intracellular
iron would significantly decrease infectivity of EB; however, no drop in infectivity was
seen between EB harvested from induced and uninduced HEK293-Fpn-GFP cells (Fig.
3.3). The only difference in infectivity was between EB harvested from HEK293-FpnGFP and HEK293 cells. Average infectivity of EB harvested from HEK293-Fpn-GFP
(with and without addition of ponasterone A) was 25% (s.d. 6) versus 39% (s.d. 7) for
HEK293.

Figure 3.3 Expression of Fpn-GFP in induced HEK293-Fpn-GFP infected cells does not
reduce infectivity of progeny elementary bodies (EB). EB were harvested from infected
host cells grown in the presence or absence of inducer, and infectivity was titrated.
Chlamydial infectivity is expressed as a ratio to HEK293 minus inducer.
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Analysis of chlamydial morphology
We also examined infected cells at 48 hours post infection (hpi) by thin section
transmission electron microscopy. Persistent inclusions are marked by aberrant
morphology, including enlarged RB and membranous blebbing [3]. Contrasting with
infected HEK293 cells containing normal chlamydial inclusions (Fig. 3.4A), HEK293
cells exposed to Desferal showed the beginnings of this characteristic morphology (Fig.
3.4B,C,D). HEK293-Fpn-GFP cells plus (4E) or minus ponasterone A (4F) induction
showed no notable differences in chlamydial morphology, although inclusions
consistently appeared less robust compared to those in HEK293 cells, regardless of
ponasterone exposure.
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Figure 3.4 Transmission Electron Microscopy (TEM) visualization of chlamydial
inclusions plus or minus exposure to 50 µM Desferal or with or without Fpn-GFP
induction. (A) Typical mid-cycle inclusions in HEK293 cells. (B,C,D) Desferal-exposed
HEK293 cells with inclusions exhibiting abherent morphology, including enlarged
reticulate bodies (RB), smaller inclusions, and membranous blebs. Image D shows a
high magnification view of chlamydial envelope ghosts and membranous ghosts.
Inclusions in HEK293-Fpn-GFP cells uninduced (E) and induced (F) show similar
morphology. Bars: (A,B,D,E,F) 5 µm; (C) 2 µm.
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Quantitation of intracellular ferritin following Desferal exposure or induction of Fpn-GFP
Because progeny EB from induced HEK293-Fpn-GFP cells did not show the
anticipated drop in infectivity, we compared the change in ferritin level in cells exposed
to Desferal, which is known to result in decreased chlamydial infectivity, to that of cells
expressing Fpn-GFP. To assure Desferal does not induce toxicity in HEK293 cells, the
Live/dead assay was used to verify there was no increase in cell death following 48 h
exposure to 50 µM Desferal versus mock-exposed cells. Expression of ferritin, the
primary intracellular iron storage protein, is tightly regulated by iron level, and is,
therefore, a useful target for measuring relative iron levels.
HEK293 cells were exposed to various concentrations of Desferal for 48 hours.
Ferritin content showed a dose-responsive drop in relation to Desferal concentration,
falling from 28.2 ng/ml (in cells not exposed to Desferal) to 3.2 ng/ml (in cells exposed
to 50 µM desferal (Fig. 3.5A). Each increase in Desferal concentration led to a
statistically significant drop in ferritin level (p< 0.01). Following incubation of HEK293Fpn-GFP cells for 48 hours, average ferritin levels dropped from 49.3 ng/ml (s.d. 10.4)
to 38.2 ng/ml (s.d. 8.3), a change that is not statistically significant (Fig. 3.5B). It is
notable that ferritin levels naturally fluctuate, which likely explain the disparity between
overall ferritin levels between HEK293 and HEK293-Fpn-GFP cells.
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Figure 3.5 Ferritin content of host cells following exposure to Desferal or expression of
Fpn-GFP. (A) Ferritin levels of HEK293 cells following 48 h exposure to 0, 5, 10, 25, or
50 µM Desferal. Asterisk indicates a significant change (p < 0.01). (B) Ferritin levels of
HEK293-Fpn-GFP cells, incubated plus or minus the inducing agent ponasterone A for
48 h.

Discussion
Because there is no established genetic system in Chlamydia, transfected
eukaryotic host cells represent one way to use genetic tools with this intracellular
bacterium. In many expression systems, tetracycline is used as the inducing agent.
While the primary effect in other applications is a decreased risk for bacterial
contamination of the culture, tetracycline is lethal for Chlamydia. In this study, we found
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no decrease in chlamydial infectivity when the inducer ponasterone was incubated with
infected HEK293 cells. Thus, ponasterone-inducible systems are a viable option for
creating host genetic systems for Chlamydia, and this is the first study known to these
authors to use a ponasterone-inducible system in Chlamydia.
Currently, the addition of the iron-chelating drug Desferal is the sole approach
used to study iron starvation in Chlamydia, and this method has proved capable of
causing chlamydiae to enter a persistent state. While Desferal is apparently effective in
starving chlamydiae for iron, it would be advantageous to have an additional method for
starving chlamydiae of iron, as the addition of a chemical agent may have pleiotropic
effects on cell viability and protein expression. For example, Desferal was found to
penetrate and cause direct damage to Pneumocystis carinii, independent of an iron
effect, and is now being considered as a treatment for patients with Pneumocystis
infections due to its toxic effect on the pathogen [20].
Over-expression of eukaryotic ferroportin was successfully used to starve a
facultative intracellular pathogen of iron in at least one other study. In a transient
ferroportin expression system, a drop in available iron was successful in limiting
intracellular growth of Salmonella enterica [21].
The goal of this project was to evaluate use of the HEK293-Fpn-GFP cell line to
create an iron-starved environment following infection with Chlamydia. Ultimately, we
found that the Fpn-GFP system used in the present study was not capable of reducing
iron below the threshold level chlamydiae require for normal development. Infectivity of
EB harvested from induced host cells did not demonstrate a drop in infectivity, and,
upon comparing ferritin levels in ponasterone-induced HEK293-Fpn-GFP cells with
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HEK293 cells exposed to Desferal, we found that Fpn-GFP induction did not lead to a
statistically significant decrease in host cell ferritin.
It is not surprising that Desferal produces a greater drop in ferritin level than FpnGFP expression. Desferal is a high affinity intracellular iron chelator that can strip iron
from all intracellular iron stores, ferritin being the major source. In iron studies where it
is undesirable to cause the chlamydiae to enter persistence through complete iron
restriction, the HEK293-Fpn-GFP cell line may be useful for generating a small
decrease in intracellular iron.
The data from Chlosta et al. (2006) suggests either Salmonella is more sensitive
to iron restriction than is Chlamydia, or the transient HeLa cell expression system used
by Chlosta et al. created a greater drop in intracellular iron than did the HEK293-FpnGFP system used in the current study. Although Chlosta et al. detected a decrease in
iron availability using a Salmonella iron-sensing promoter assay, they did not use a
quantitative measure of intracellular iron. This would have allowed comparison of the
relative efficacy of iron efflux in their Fpn expression system to that of the HEK293-FpnGFP system used in this study.
The HEK293-Fpn-GFP cells used in this study were previously used to elucidate
the relationship between ferroportin and the peptide hormone hepcidin [18]. The
experimental procedure used by Nemeth et al. (2004) included supplementing the
medium with iron prior to Fpn-GFP expression. Expression of Fpn-GFP caused ferritin
levels to return to the pre-supplementation level, a much greater decrease than seen in
the current study. This may mean that the Fpn-GFP model requires a higher initial
concentration of intracellular iron for effective efflux. Because the critical factor for
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restricting iron from an intracellular pathogen is iron level rather than the change in iron
level, supplementing the iron level prior to Fpn-GFP induction would have been
ineffective in this study. Thus, we conclude inducing HEK293-Fpn-GFP is ineffective in
producing an iron-restricted environment during C. trachomatis serovar E infection such
that the chlamydial developmental cycle is altered.
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Abstract

The obligate intracellular bacterium Chlamydia trachomatis serovar E is the most
prevalent cause of bacterial sexually transmitted disease. With an established
requirement for iron, the developmental cycle arrests at the intracellular reticulate body
stage during iron restriction resulting in a phenomenon termed persistence. Persistence
has implications in natural infections for altered expression of virulence factors and
antigens in addition to a potential role in producing chronic infection. In this study,
chlamydial proteins in iron-restricted infected HEC-1B were radiolabeled during middevelopmental cycle growth, harvested, and separated using two-dimensional
polyacrylamide electrophoresis (2D-PAGE). Of ~250 radiolabeled protein species
visualized, densitometric analysis revealed 25 proteins that increased in expression
under iron restriction compared to iron-sufficient control samples; 10 protein species
identified by mass spectrometry are involved in the oxidative damage response (alkyl
hydroperoxide reductase, 6-phosphogluconlactonase, and acyl carrier protein
synthase), transcription (RNA polymerase subunit alpha and transcription antitermination factors NusA and NusG), protein modification (peptide deformylase and
trigger factor), and virulence (CADD). Transcript-level expression patterns of ahpC,
devB, cadd, fabF, and ct538 were measured by quantitative PCR throughout the
developmental cycle, and each gene examined demonstrated a significant but small
mid-cycle increase in transcript level in iron-restricted cultures compared to iron-replete
controls. Taken together, these data suggest that the primary response of chlamydiae
to reduced iron availability is to increase expression of proteins involved in protection
against oxidative damage via iron-catalyzed generation of reactive oxygen species and
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adaptation to stress by increasing expression of transcriptional machinery and other
stress responsive proteins.
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Introduction
Chlamydia trachomatis is an obligate intracellular pathogen of human genital and
ocular mucosal epithelia. C. trachomatis serovars D-K are the number one cause of
bacterial sexually transmitted disease worldwide with 92 million new infections a year
(62); in 2006, more than 1 million new cases were reported to the Centers for Disease
Control and Prevention in the United States alone (10). While genital infections caused
by the non-invasive serovars D-K are commonly asymptomatic and limited to the lower
genital tract, an ascending infection marked by inflammation-induced damage can
develop and lead to severe sequelae including endometritis and pelvic inflammatory
disease.
Chlamydiae exhibit a biphasic developmental cycle marked by conversion
between the extracellular, infectious form termed the elementary body (EB) and the
intracellular, metabolically active reticulate body (RB). The developmental cycle can be
interrupted by induction of persistence in which division of the RB ceases and
conversion to the EB is prevented. Identified inducers of persistence include interferon-γ
or penicillin exposure and nutrient deficiency. Although chromosomal replication
continues, cellular division ceases, RB become enlarged, and transcription and protein
expression profiles are altered; additionally, persistent chlamydiae are refractory to
killing by some antibiotics and expression of antigens continues during the prolonged
development cycle (21). Persistence has become an issue of interest in chlamydial
pathogenesis due to the potential role in establishing chronic infection, which can result
to the development of more severe disease outcomes.
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Iron is required as a cofactor in numerous ubiquitous cellular metabolic
processes in both bacterial and eukaryotic cells, including cytochromes, ribonucleotide
reductase, RNA polymerase III, amino acid hydroxylases, superoxide dismutase,
catalase, and peroxidase (4, 61). Free iron concentrations are kept low in biological
systems because unbound iron catalyses free oxygen radicals through the Fenton
reaction, which results in damage to lipids, proteins, and nucleic acids (32, 54, 61). In
mammals, iron-binding proteins, such as transferrin, lactoferrin, and ferritin, chelate free
iron, and transport of iron into cells is tightly regulated in response to intracellular iron
level (28, 38). Additionally, control of intracellular iron level plays a role in innate
immunity through general limitation of iron to prevent infection and increased limitation
in response to infection (24, 31, 48). Indeed, all examined microbial organisms have an
absolute requirement for iron except lactobacilli (5, 59) and Borrelia burgdorferi (40),
which use alternative transition metal cofactors including cobalt and manganese.
Further, reduced iron availability is known to induce virulence factors in pathogens, such
as the shiga toxin in Shigella dysenteriae, the shiga-like toxin in E. coli, exotoxin A in
Pseudomonas aeruginosa, and diptheria toxin in Corynebacterium diptheriae (19, 29).
Iron has been shown to be necessary for normal chlamydial development, and
iron restriction leads to chlamydial persistence. When intracellular iron is chelated by
deferoxamine mesylate (Desferal) in vitro, the development cycle of C. trachomatis
arrests at the RB stage and cell division ceases; also, enlarged aberrant chlamydial
forms are visible by transmission electron microscopy (42). It is clear that iron restriction
induces persistence rather than killing the chlamydiae, as these effects on the
chlamydiae are reversible upon addition of an iron source. Similar observations in
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response to iron restriction have been made in Chlamydophila pneumoniae (1, 15) and
Chlamydophila psittaci (16).
The first investigation to describe the chlamydial requirement for iron identified
several iron responsive protein species by separation of radiolabeled protein from
purified EB (42). Notably, two proteins demonstrated in that study to be iron responsive
have garnered interest due to their immunogenicity in Chlamydia-infected patients:
cHsp60-2 (26) and YtgA (43). During menstruation, iron levels in endometrial cells
fluctuate, and thus bacteria infecting these cells encounter an additional level of iron
limitation (2, 3, 11, 25); therefore, the response of chlamydiae to reduced iron
availability has dramatic health implications, especially considering the highest
incidence of chlamydial infections occurs in females between 15 and 24 years of age
(10).
While the chlamydial requirement for iron is well established, the identification of
processes and pathways upregulated under iron restriction have been hindered by the
lack of a direct system for genetic manipulation in Chlamydia and the lack of identifiable
homologues to proteins involved in conserved iron responses in other bacteria, such as
pathways for siderophore production. The goal of the present work was to identify
proteins increasingly expressed in metabolically-active chlamydiae growing under iron
restriction, followed by analysis of the corresponding transcripts for a subset of these
proteins, in order to better elucidate the chlamydial response to iron restriction.
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Materials and Methods
Host cells, chlamydiae, and iron restriction conditions
Human endometrial carcinoma epithelial HEC-1B cells (HTB-113, ATCC) were
grown at 37°C with 5% CO2 in Dulbecco’s Modified Essential Medium (D-MEM, Gibco,
Grand Island, NY) supplemented with 10% (v/v) fetal bovine serum (HyClone, ) and 2
mM GlutaMax (Gibco, Logan, UT) in 6-well plates.
For iron restriction, HEC-1B cells were incubated 24 hours prior to infection in
medium containing 5% FBS plus or minus 50 µM of the iron chelator Desferal
(deferoxamine mesylate, Sigma-Aldrich, St. Louis, MO). Cultures were incubated with a
C. trachomatis serovar E inoculum titrated to infect 80% of host cells. After a 1 h
adsorption step at 35°C, inoculated HEC-1B cells were returned to medium plus or
minus Desferal containing 0.5 µg/ml cycloheximide, conditions that have previously
been shown to induce persistence in C. trachomatis (42). In some protein analysis
experiments, Percoll-purified EB, prepared using a standard protocol, were used. HEC1B and C. trachomatis stocks were routinely tested for Mycoplasma contamination by
the VenorGem PCR test (Sigma-Aldrich).

Host cell iron level determination via ferritin assay
The Spectro Ferritin enzyme immunoassay (Ramco Laboratories, Stafford, TX) was used
to measure ferritin levels in infected HEC-1B protein samples collected at 24 hours postinfection (hpi), according to the manufacturer’s instructions. All samples were assayed in
triplicate, and ferritin levels were normalized for variations in protein concentration (BCA assay,
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Pierce, Rockford, IL). A two-tailed Student’s t-test was used to determine significance for a
change in ferritin concentration.

Protein radiolabeling
Protein radiolabeling was conducted in Chlamydia-infected HEC-1B cells
between 22 and 24 hpi. Cultures were incubated in D-MEM lacking methionine and
cysteine and supplemented with 5% FBS, 2 mM GlutaMax, 40 µg/ml cycloheximide,
plus or minus 50 µM Desferal, and 100 µCi/ml 35S-labeled methionine and cysteine
(Redivue PRO-MIX, GE Healthcare, Buckinghamshire, UK) for 2 h at 35°C. Following
labeling, monolayers were washed with PBS and harvested in deionized water
containing 1% CHAPS and a general protease inhibitor cocktail (Pierce) and stored at 20° C.

Sample preparation and protein separation
Radiolabeled protein samples collected from iron-restricted or normally grown C.
trachomatis-infected HEC-1B cells were separated via two-dimensional polyacrylamide
electrophoresis (2D-PAGE). Briefly, following desalting using Zeba Desalt spin columns
(Pierce), samples were assayed for protein concentration by the BCA assay (Pierce)
and the degree of radioisotope incorporation for each sample was determined by
scintillation of TCA-precipitated protein from each sample. Protein samples were
solubilized in Bio-Rad (Redman, WA) rehydration/sample buffer (8M urea, 50 mM DTT,
2% CHAPS, 0.2% Bio-Lyte 3/10 carrier ampholytes, 0.001% Bromophenol Blue).
Protein loads for quantitative gels were equalized to one million cpm and 300 µg total
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protein; preparative gels for mass spectrometry identification were loaded with 2 mg of
total protein from unlabeled Percoll-purified EB and spiked with 250,000 cpm from a
labeled protein sample to facilitate matching of EB protein spots with radiolabeled
proteins of interest.
First dimensional isoelectric focusing (IEF) was conducted on a PROTEAN IEF
cell with 17 cm isolated pH gradient (IPG) strips with a pH range of 4-7 (Bio-Rad). The
pH range of 4-7 was selected because this range encompassed the majority of labeled
proteins and allowed for better resolution compared to a wider range separation. The
focusing conditions were as follows: 50 µA limit per IPG strip; 250 V maximum for 15
min, 10,000 V maximum for 2h, and 10,000 V maximum for 60,000 volt-hours.
Following IEF, strips were equilibrated for 20 min in equilibration buffer 1 (6 M
urea, 2% SDS, 375 mM Tris-HCl, 2% DTT, 30% glycerol), followed by 20 min in
equilibration buffer 2 (same formulation except 2.5% iodoacetamide substituted for
DTT). Separation in the second dimension was done using PROTEAN II 10% Tris-HCl
Ready Gels (Bio-Rad). Gels were run at 24 mA per gel for approximately 5 hours.
Gels for quantitative analysis were fixed in 25% methanol and 10% acetic acid,
incubated with Amplify fluorographic reagent (GE Healthcare) for 30 minutes, vacuum
dried, and exposed to phosphor screen for 14 days. Phosphor screens were scanned
with the Bio-Rad Molecular Imager FX using Quantity One software (Bio-Rad).
Preparative gels were fixed in 50% methanol and 7% acetic acid, stained with GelCode
Blue Coomassie (Pierce), vacuum dried, and exposed to X-ray film for 14 days. Two
replicate gels were run from each of four biological replicates.
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Protein spot quantitation and identification
Protein spots were matched and analyzed for differential expression using
Dymension software (Syngene, Fredrick, MD). Protein spot intensities were normalized
to the total valid spot intensity for each gel. Proteins were deemed iron responsive if (i)
the average density of the protein spot from iron-restricted samples showed a two-fold
or greater increase over control samples and (ii) P value < 0.05 using Student’s two-way
t-test.
Protein spots demonstrating a significant increase in density between the ironreplete and iron-restricted samples were excised from preparative gels and submitted
for identification via liquid chromatography-tandem mass spectrometry (LC-MS/MS).
True matches between detected peptides and protein identities were affirmed by a
Mowse score indicating a P < 0.05 and by comparing predicted versus observed pI and
molecular weight.

Quantitative PCR analysis
Transcript levels of ahpC, devB, cadd, fabF, and ct538 were measured using
quantitative reverse transcription PCR (qRT-PCR). HEC-1B cells were grown in 6-well
plates and iron-starved 24 hours prior to infection as described above. Following
infection, monolayers were collected at 6, 12, 18, 24, 36, and 48 hpi, along with
uninfected control samples. After washing with PBS, each monolayer was scraped with
a rubber policeman into RLT lysis buffer (Qiagen, Valencia,CA), passed through a 20gauge needle 10 times, and stored at -80° C. Samples were collected at least in
triplicate on separate occasions. Collected samples were split into two aliquots for
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separate RNA and DNA purifications. RNA was purified using the RNeasy Mini kit,
including an on-column DNase step (Qiagen), and genomic DNA (gDNA) was purified in
parallel using the QIAamp Blood DNA Mini kit (Qiagen). RNA integrity was verified
using the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA), and RNA and
DNA concentrations were determined by spectrophotometer reading at 260 nm. An
equal amount of total RNA for each sample was reverse transcribed using random
hexamers and SuperScript II Reverse Transcriptase (Invitrogen, Carlsbad, CA),
following the conditions recommended by the manufacturer.
qPCR was conducted on samples in triplicate using the Bio-Rad iCycler.
Reaction mixtures contained 1x Platinum Quantitative PCR Supermix-UDG (Invitrogen),
0.8x SYBR green (Cambrex BioScience, Rockland, ME), 5 mM MgCl2, 300 nM
concentrations of each primer, and 1 µl of sample in a total volume of 50 µl. Primer
sequences for each gene are given in Table 4.1. The specificity of each primer set was
confirmed by sequencing of the amplicons. To correct for loading variations, chlamydial
chromosome copy numbers were normalized to total DNA. Assay validation and
quantitative analyses were performed using a standard curve method as described
previously (18). The amplification efficiencies of all assays ranged from 94% to 102%.
Controls included (i) uninfected samples to demonstrate specificity of primers for
chlamydial targets and (ii) RT minus samples, in which the reverse transcription was
omitted in order to determine chlamydial gDNA contribution to the qPCR signal for
corresponding RT plus samples. Chlamydial genome copy number for each
experimental sample was determined by qPCR using the ct538 primer set against
gDNA. Transcript levels are presented as copy number per chlamydial genome.
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Table 4.1 C. trachomatis-specific oligonucleotide primers used in qPCR analyses.a
Gene

a

Amplicon
length
88 bp

Forward primer (5’ to 3’)

Reverse primer (5’ to 3’)

ahpC

CCAGTTAGCTGGACAAACCATTCCG

CGTTCCATTGACGAGGAATTGCGT

fabF

GGAATTAGTGGAGTGCGAACA

GGATCAACTCGTCTAGCTTGT

128 bp

devB

ACGAAGATGTAGAAGCTGGAAGTA

TGCGGTATCCATACGAAAGATTTG

98 bp

cadd

GACAACTACAACAAGTTCCTG

GTTAGAGGCATCGCAAGA

83 bp

ct538

GTTTGACAGCTACACCACTCTG

AACGTCTACGCAAACCCTCA

91 bp

Primers were designed using the published C. trachomatis serovar D sequences.

Results
Host cell ferritin content
In order to demonstrate that intracellular iron levels decreased in response to
Desferal exposure and, therefore, chlamydiae were restricted for iron, host cell ferritin
levels were measured by a immunoassay. Measurement of ferritin content is a
commonly used method to indirectly determine iron levels in eukaryotic cells because
ferritin expression is regulated by cellular iron level. Ferritin content was measured in
samples collected from mock- and Desferal-exposed HEC-1B cultures infected with C.
trachomatis serovar E for 24 h (Fig. 4.1). Ferritin levels in Desferal-exposed samples
averaged 119 ng/ml compared to 241 ng/ml in mock-exposed samples. This two-fold
difference between Desferal-exposed and unexposed samples was statistically
significant, thereby validating this model for iron restriction of Chlamydia-infected cells.
Additionally, exposure of uninfected cells to Desferal as above resulted in a similar drop
in ferritin level (data not shown).
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Figure 4.1 Effect of Desferal exposure on Chlamydia trachomatis serovar E-infected
HEC-1B ferritin levels. Ferritin levels were measured by enzyme immunoassay in
infected cultures exposed to 50 µM Desferal or mock-exposed. Samples with a
significant difference (P < 0.05) from mock-exposed host cells are marked by asterisks.
The average of 4 independent experiments are presented (+/- SD).

Separation of chlamydial proteins and analysis of differential protein expression in
response to iron availability
In order to identify differences in protein expression levels between chlamydiae
growing in iron-replete or restricted conditions, C. trachomatis serovar E-infected cells,
growing in the presence or absence of the iron chelator Desferal, were pulse labeled at
22-24 hpi. This labeling window was chosen because it is during logarithmic growth
(21), which coincides with an increased demand for micronutrients such as iron. Host
cells were starved for iron 24 h prior to infection to ensure chlamydiae did not obtain
iron stores early in infection. At 22 hpi, medium for each sample was switched to the
radiolabeling media, the infection was allowed to continue for 2 hours of labeling, and
protein samples were collected, processed, and separated via 2D-PAGE. This
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methodology for generation of proteomic maps in C. trachomatis were adapted from the
pioneering chlamydial proteomic studies by Vandahl, Birkelund, and Christiansen (57).
Approximately 250 protein spots were visible via radiography (Fig. 4.2). Using
Dymension 2D-PAGE analysis software, 25 proteins were determined to increase in
expression during iron-restricted growth relative to iron-sufficient growth, with a
threshold of ≥2-fold expression difference and a P <0.05 given by Student’s two-way ttest (Fig. 4.3).
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Figure 4.2 Representative two-dimensional electrophoretic maps of C. trachomatis
proteins radiolabeled 22-24 hpi under iron-sufficient (A) and iron-restricted (B) growth
conditions. Proteins were separated on 17 cm immobilized pH gradients (pI 4-7) in the
first dimension and by SDS-PAGE (10%) in the second dimension. Identified iron
responsive protein spots are labeled with arrows. Isoelectric point (pI) and molecular
weight are indicated.
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Figure 4.3 Representative two-dimensional polyacrylamide electrophoresis of ironresponsive proteins with relative expression levels. Raw images of spots from samples
collected from iron-restricted (Des+) or iron-sufficient (Des-) Chlamydia-infected HEC1B cells were combined prior to adjusting contrast in Adobe Photoshop in order to
preserve the relative spot intensities. Graphs indicate normalized volume of protein
spots.

Identification of iron responsive proteins by mass spectrometry
Protein spots from preparative 2D gels containing purified EB protein were
matched to corresponding spots on radiographs, excised, and submitted for
identification via LC-MS/MS. Of the 25 spots found to be more highly expressed in
iron-restricted cultures, 10 proteins were expressed at a high enough level to allow
mass spectrometric identification (Table 4.2; Fig. 3).

89

Table 4.2 Identified C. trachomatis serovar E iron responsive proteins
Functional
Group
Metabolism/
biosynthesis

ORF

Protein
name

CT603

AhpC
(TSA)

CT186

Fold
pI / MW
UniProt
a
b
c
accession increase predicted

Description

pI / MW
observed

alkyl hydroperoxide reductase
(thio-specific antioxidant peroxidase)

O84608

6.4

4.8 /
22 kDa

4.6 /
22 kDa

DevB
(6PGL)

6-phosphogluconolactonase

O84189

2.1

5.3 /
29 kDa

5.3 /
28 kDa

CT770

FabF

acyl carrier protein synthase

O84775

2.6

5.4 /
45 kDa

5.6 /
42 kDa

CT353

Def

peptide deformylase

O84357

3.8

5.7 /
21 kDa

5.8 /
21 kDa

CT707

RopA

trigger factor
(peptidyl prolyl cis-trans isomerase)

O84713

3.7

5.0 /
50 kDa

5.2 /
50 kDa

CT507

RpoA

RNA polymerase subunit alpha

Q46449

3.1

5.3 /
42 kDa

5.4 /
40 kDa

CT097

NusA

transcription anti-termination factor

O84099

2.1

5.2 /
49 kDa

5.5 /
50 kDa

CT320

NusG

transcription anti-termination factor

O84322

5.9

5.3 /
21 kDa

5.3 /
18 kDa

Virulence

CT610

CADD

Chlamydia protein Associating with Death
Domains

O84616

3.4

4.9 /
27 kDa

5.0 /
26 kDa

Hypothetical

CT538

-

hypothetical protein

O84543

2.9

5.2 /
27 kDa

5.3 /
27 kDa

Protein
modification

Transcription

a

Accession number for C. trachomatis serovar D proteins.
Fold increase in spot volume in iron-restricted versus iron-sufficient growth conditions as determined by analysis with Dymension
2D software. Average value from 2 replicate gels from each of 4 independent experiments.
c
Calculated using ExPASy Compute pI/MW tool.
b

Interestingly, 9 of these iron responsive proteins have been assigned a putative
function by homology to genes known in other bacteria. AhpC (alkyl hydroperoxide
reductace subunit C), a protein involved in protecting the cell from oxidative damage,
showed a 6.4-fold increase in expression by iron-restricted versus iron-replete
chlamydiae, the highest degree of iron responsiveness of the proteins identified in this
study. Two proteins involved in biosynthesis pathways were also identified as iron
responsive, DevB (6-phosphogluconolactonase) and FabF (3-oxoacyl-[acyl-carrierprotein] synthase), for which a 2.1-fold and a 2.6-fold increase in expression was found,
respectively, in response to iron restriction.
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Two chlamydial proteins with putative roles related to protein modification, i.e.
RopA (trigger factor or peptidyl prolyl cis-trans isomerase) and Def (peptide
deformylase), were found to be iron responsive, with 3.7-fold and 3.8-fold increased
levels in iron-starved samples compared to control samples. Three proteins involved in
transcription were also identified. Indeed, in response to iron restriction, RpoA (RNA
polymerase subunit alpha) increased 3.1-fold, while the transcription elongation
proteins NusA and NusG increased 2.1-fold and 5.9-fold, respectively. In addition,
putative virulence factor CADD (Chlamydia protein associating with death domains)
expression was found to increase 3.4-fold. Lastly, the uncharacterized protein CT538
demonstrated a 2.9-fold increase in expression.

Transcriptional analysis of selected genes
qPCR was used to examine transcript levels of a subset of the identified ironresponsive proteins, i.e. ahpC, devB, fabF, cadd, and ct538. These transcripts were
selected due to their potential role in the oxidative response (ahpC, devB, and fabF), the
putative role of cadd in chlamydial virulence, and the fact that ct538 is uncharacterized.
Transcript levels were measured at 6, 12, 18, 24, 36, and 48 hpi in iron-restricted and in
mock-exposed control chlamydiae using qPCR. Analysis of transcript levels normalized
to chlamydial chromosome copy number revealed that the transcript levels for all five
genes examined peaked at 18 hpi (Fig. 4.4). It is not surprising that the level of these
transcripts would be highest mid-cycle, considering the relatively high expression of
these proteins during radiolabeling, 22-24 hpi.
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Figure 4.4. Chlamydial transcript levels at selected times throughout the developmental
cycle from infected cultures grown under normal or reduced iron conditions. Times at
which transcripts are significantly increased in iron-restricted (D+) versus iron-sufficient
(noD) growth are marked by asterisk.

Mid-cycle levels increased for each transcript in samples from iron-restricted
chlamydiae compared to samples from iron-replete chlamydiae at either 18 or 24 hpi (P
< 0.05; Fig. 4.4). Transcript levels of cadd reached a higher peak level at 18 hpi in
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samples from iron-restricted cultures compared to iron-replete cultures. In contrast,
ahpC, devB, fabF, and ct538 transcript levels peaked at similar levels under both growth
conditions at 18 hpi; however, in samples from iron-restricted chlamydiae, higher levels
of these transcripts were detected at 24 hpi compared to samples from iron-replete
chlamydiae. Because protein expression differences between iron-restricted and ironreplete samples were higher than transcript level differences, the duration of heightened
transcript level may be more important for regulation of protein expression under iron
restriction than changes in maximal transcript levels.

Discussion
The goal of this study was to identify chlamydial proteins showing increased
expression during intracellular growth in iron-restricted compared to iron-replete host
cells. Little is known about chlamydial responses to altered iron availability, aside from
the requirement for sufficient iron. In addition to helping to characterize the chlamydial
iron stimulon, identifying proteins increasingly expressed during iron restriction also
defines modulation of protein expression during chlamydial persistence. In the current
study, 10 C. trachomatis serovar E iron responsive proteins were identified by 2D-PAGE
coupled with mass spectrometry.
The primary iron regulatory protein in Gram-negative bacteria is the
transcriptional repressor Fur, which acts via binding, in the presence iron, to specific
regions in the promoter region of regulated genes termed Fur boxes. Of the
approximately 90 Fur-regulated genes in Escherichia coli, 60 of these encode
siderophore-related proteins, 13 encode virulence factors and toxins, and 18 encode
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proteins involved in iron storage and the oxidative stress response (19). In the present
study, C. trachomatis iron responsive proteins involved in oxidative stress response and
virulence were identified, but none appear to be directly involved in iron acquisition.
This may be surprising considering the obvious necessity for upregulating iron
acquisition during iron limitation; however, no genes encoding conserved iron
acquisition mechanisms, such as siderophores, were identified following the sequencing
of the chlamydial genome (50), although a putative component of an ABC metal
transporter, YtgA, has been identified in Chlamydia (43).
The lack of obvious iron-uptake system homologs in Chlamydia suggests that
these organisms (i) possess conserved iron acquisition genes with highly divergent
sequences or (ii) use alternative or novel iron acquisition systems. The pathways by
which intracellular organisms acquire iron are much less defined compared to those
used by extracellular bacteria, but it appears to involve alternative systems. For
example, iron reductases are believed to play a role in iron acquisition by Listeria
monocytogenes through the removal and solubilization of iron from iron binding proteins
like heme, ferritin, and transferrin (12). Interestingly, a recent study has shown that
reduced expression of transferrin or Rab11, a protein involved in trafficking of
transferrin-positive vesicles, leads to a decrease in the production of infectious EB (20).
An analog to Fur, termed DcrA, was identified in C. trachomatis serovar E, and
has shown the ability to bind E. coli Fur boxes (63). Putative DcrA binding sites have
been identified in the chlamydial genome by binding of purified E. coli Fur protein (41).
Notably, binding sites for DcrA have been identified upstream of genes encoding two
proteins found to be iron responsive in the current study, AhpC and FabF.
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Mukhopadhyay et al. (35) conducted a proteomic analysis of Chlamydophila
pneumoniae that examined protein expression modulation by three inducers of
persistence: iron restriction, heat shock, and interferon-γ exposure. Proteins
increasingly expressed under iron restriction but not following heat shock or interferongamma exposure were involved in cofactor biosynthesis, cellular processes, and
translation, including one protein identified as iron responsive in the current study,
AhpC. In another study, interferon gamma exposure was shown to increase expression
of AhpC (36) and RpoA (34) in C. pneumoniae and to upregulate transcription of ahpC
in C. trachomatis (6). Interferon gamma has pleiotropic effects on the host cell including
tryptophan limitation, synthesis of nitric oxide species, and iron restriction (23). While
these studies may indicate AhpC and RpoA are increasingly expressed as a part of a
non-specific stress response, it is possible that expression of these proteins is induced
by the iron limitation component of the host cell’s response to interferon-γ.
The close connection between the response to iron availability and oxidative
stress in bacteria and eukaryotes is well established. AhpC belongs to a family of
antioxidant proteins that are responsible for the reduction of peroxides and is
expressed in response to oxidative stress. In E. coli, expression of AhpC is controlled
by the regulator of oxidative stress OxyR (64). Bacillus subtilis and Campylobacter
jejuni possess a Fur homologue named PerR that regulates genes involved in the
oxidative-stress response, including ahpC (8, 55). Furthermore, decreased iron
availability has been shown to modulate expression of ahpC transcription and/or AhpC
protein expression in numerous organisms, including Helicobacter pylori (33),
Corynebacterium diptheriae (52), Campylobacter jejuni (56), and Francisella tularensis
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(27).
Two chlamydial proteins involved in biosynthetic pathways, DevB and FabF,
were found to be iron responsive in the present study. DevB catalyzes the hydrolysis of
6-phosphogluconolactone to 6-phosphogluconate, the second step of the pentose
phosphate pathway (PPP), while FabF catalyzes the chain-elongation step of type II
fatty-acid biosynthesis. Like AhpC, the PPP is also involved in the response to
oxidative conditions, through the generation of NADPH, which serves as an electron
source for reductases and antioxidants. Another PPP enzyme, glucose-6-phosphate
dehydrogenase (G6PD), is regulated by the E. coli soxR system involved in oxidative
defense (53). G6PD mutants of E. coli (37), Salmonella typhimurium (30), and mouse
stem cells (39) have extreme sensitivity to oxidative damage. In addition to a role in
oxidative protection, the PPP may be more important for generation of energy under
iron restriction because iron-containing species such as cytochromes are required for
the TCA cycle.
FabF is also likely iron responsive due to a role in oxidative damage defense
because increased expression of other enzymes involved in fatty acid biosynthesis
appear to be involved in the iron restriction and oxidative responses in other bacteria.
For example, FabH expression is involved in hydrogen peroxide resistance and is coregulated with siderophore production in Pseudomonas syringae (51), while Francisella
tularensis (27) and Campylobacter jejuni (22) increase expression of FabG under iron
restriction.
Two proteins responsible for protein modification were found to be iron
responsive in this study: RopA and Def. RopA is a chaperone involved in protein folding
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in conjunction with DnaK (14) and appears to have a role during oxidative and other
stresses. Streptococcus mutans upregulates transcription of ropA under low iron (44),
and ropA mutants are less tolerant to acid or oxidative stress than the wild type strain
(60). RopA expression may be required for correct processing of other iron responsive
proteins. In E. coli lacking RopA and DnaK, numerous proteins were incorrectly folded,
including two proteins identified as iron responsive in the current study, FabF and RpoA,
as well as 6-phosphogluconate dehydrogenase, an enzyme that functions with DevB in
the PPP (58).
Def catalyzes the removal of the formyl group from the N-terminal L-methionine
of nascent peptides. Altered expression of Def could serve as a regulatory mechanism
for substrate proteins, as formylated proteins are inactive or because it is an ironrequiring enzyme. The transcription of def has been shown to increase during iron
restriction of Francisella tularensis (13). In a Staphylococcus aureus study, induction of
the TCA cycle resulted in increased secretion of formylated δ-toxin relative to the typical
deformylated form (47), which was hypothesized to be a result of the increased
consumption of iron by enzymes required for the TCA cycle because Def has a di-iron
center that is required for activity. Thus, increased expression of Def by iron-restricted
chlamydiae may reflect the production of inactive enzyme, which could activate a
feedback loop to increase expression. Additionally, Def activity may play a role in the
immunological response to chlamydial infection, as formylated protein has been shown
to be a chemoattractant to neutrophils (45).
Three proteins required for transcription were identified. RpoA, as part of RNA
polymerase, catalyzes the transcription of DNA into RNA. NusA and NusG are
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transcription elongation proteins that bind to RNA polymerase and the transcription
terminator Rho in order to regulate transcriptional activity by modulating pausing, arrest,
termination, and anti-termination of RNA polymerase (7). Increased expression of these
transcription factors may be involved in regulating transcription under iron restrictive or
oxidative stress, as numerous transcripts encoding proteins involved in transcription and
translation, including RpoA, were upregulated following iron restriction of Neisseria
meningitidis (17) and Francisella tularensis (27).
The finding that CADD is iron responsive is significant because it is involved in
induction of host cell death via interaction with the death domains of Fas (49) and
possibly enzymatic action as a redox protein (46). CADD is one of several identified
factors chlamydiae express that is involved in induction or inhibition of host cell death.
Inhibition of apoptosis has been hypothesized to promote chronic infections (i.e.
persistence), while activation of cell death is thought to be the chlamydial strategy to
prevent a dying host cell from entering necrosis, which is pro-inflammatory (9). In the
case of iron restriction, chlamydiae may sense this as a sign of a dying host cell or a
cellular response to interferon-γ. Notably, a microarray study showed cadd transcript
levels of C. trachomatis serovar D increased in response to interferon-γ exposure by
2.85-fold (6).
In summary, the analysis of chlamydial protein expression alterations during iron
restriction at mid developmental cycle growth shows an increase in expression of
proteins involved in protection against oxidative damage and response to stress by
increasing expression of transcriptional machinery and other stress responsive proteins.
Further, this has been matched with an increased level of transcript encoding five of the
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identified proteins during mid-developmental cycle. While the mechanisms used by
chlamydiae to obtain iron remain elusive, the concept that chlamydiae have a reliance
on iron availability is clearly indicated by the demonstrated metabolic alterations
associated with iron restriction.
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CHAPTER 5

CONCLUSION

Intracellular growth provides a protected environment for pathogens that have
evolved mechanisms to invade the host cell; however, obtaining required nutrients and
avoiding cellular defense mechanisms provides challenges to intracellular survival.
Intracellular iron levels are carefully controlled in eukaryotic cells due to the reactive
nature of free iron, and, furthermore, detected infections activate pathways to further
restrict available iron. Chlamydiae require iron in order to complete a productive
development cycle because reduced iron availability induces persistence. Extending
the knowledge of how Chlamydia respond to iron limitation is critical because of the
potential role in pathogenesis as well as to contribute to the understanding of the
response of intracellular bacteria to iron restriction.
The focus of this lab has been characterizing the response of C. trachomatis
serovar E to iron, including protein expression alterations (Raulston 1997; LaRue and
others 2007), transcriptional response and regulation (Wyllie and Raulston 2001; Rau
and others 2005), and potential iron acquisition pathways (Raulston and others 2007).
In this dissertation, evidence has been presented that (i) chlamydiae increase
expression of cHsp60-2 in response to iron restriction, (ii) Desferal-exposure of host
cells, but not induction of a recombinant ferroportin protein, resulted in a drop in the
intracellular iron level sufficient to induce the altered, chlamydial persistent state, and
(iii) 10 chlamydial proteins showing increased expression during iron-restricted growth
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have been identified, and an increased transcript level of a subset of genes encoding
these proteins was also observed under iron restriction.
The first study investigated the expression of each of three chlamydial heat
shock protein 60 homologs (cHsp60-1, cHsp60-2, and cHsp60-3) during iron restriction
of Chlamydia-infected, polarized human endometrial epithelial cells using peptide
antisera generated to be specific for each (LaRue and others 2007). Chlamydial Hsp60
has a long history of being implicated in chlamydial pathogenesis through the
correlation of patients developing more severe disease outcomes with the presence of
antiserum reactivity against the protein; thus, the finding that cHsp60 exhibited an
increase in expression following iron restriction was intriguing (Raulston 1997). The
sequencing of the chlamydial genome identified three cHsp60 homologs (Stephens and
others 1998), which begged the questions as to whether each homolog had a different
function and which homolog or homologs were iron responsive.
Gene fragments specific for each gene were PCR-amplified and cloned into a
pBAD vector for expression in Escherichia coli (Figure 2.1), and antisera were
generated by inoculation of rabbits with these peptides. To generate protein samples
for Western blot, chlamydiae were grown in host cells exposed to Desferal or mockexposed control. For this study, a short exposure to a high concentration of Desferal
was used (500 µM, compared to 50 µM, for 30 min to 2 h prior to collecting protein
samples), in order to provide an iron restriction “shock” that may be more appropriate
for analysis of these heat shock proteins.
Each antiserum was confirmed to be specific for the correct cHsp60 homolog
(Figure 2.2A). Western blots labeled with polyclonal monospecific antibodies generated
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against each cHsp60 homolog revealed that while cHsp60-1 and Hsp60-3 expression
remained constant, a dramatic increase in expression of cHsp60-2 occurred 30 min
following Desferal exposure, an effect that diminished at 1 and 2 h following exposure
(Figure 2.2B). These results were confirmed by immunoelectron microscopy of infected
host cells. Increased second affinity labeling of antibody-conjugated gold particles was
observed in samples probed with antiserum against cHsp60-2 exposed to Desferal 1 h
compared to the mock-exposed control, while antisera against cHsp60-1 and cHsp60-3
showed no change between Desferal and mock-exposed growth (Figure 2.3). Thus,
this paper demonstrates that expression of cHsp60-2 increases under iron-restricted
growth.
In the second study, a novel model for studying iron restriction in Chlamydia was
investigated, at the suggestion of a colleague, Dr. Jerry Kaplan. While Desferal
exposure has been shown to induce iron restriction in chlamydiae (Raulston 1997),
exposure of host cells and bacteria to this type of exogenous chemical can result in
pleiotropic effects, perhaps undetected, on the model system. In the case of Desferal, it
is known to have toxic effects on Pneumocystis carinii independent of an iron effect
(Clarkson and others 2001). Thus, a project to develop an additional and complimentary
iron restriction model was undertaken.
We obtained from Dr. Kaplan HEK293 cells stably transfected with a ferroportingreen fluorescent protein fusion (Fpn-GFP), which is inducible by addition of the insect
hormone analog ponasterone (Nemeth and others 2004). Ferroportin is critical for iron
homeostasis in mammals, as it is the only known cellular iron efflux protein (Ganz
2005).
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In order to determine the timing of Fpn-GFP expression following induction, a
fluorescence time course was conducted. Expression of Fpn-GFP, marked by the
appearance of fluorescence, appeared at 12 h after induction, intensified at 24 h, and
persisted through 36h -- the last time examined (Figure 3.1). Additionally, cell viability
was monitored in order to verify that induction of Fpn-GFP did not increase cell death,
which would influence infectivity determination (Figure 3.2). Induction did not increase
cell death, although the Fpn-GFP-transfected cell line showed a higher rate of death
than the untransfected control cell line.
Iron-restricted chlamydiae enter persistence that prevents maturation of RB into
EB. If the expression of Fpn-GFP in infected cells caused chlamydiae to be restricted
for iron, there should be a decreased level of infectivity from progeny EB.
Unfortunately, induction of Fpn-GFP in infected cells did not reduce the infectivity of
progeny EB and, thus, chlamydiae did not enter persistence (Figure 3.3). Additionally,
transmission electron microscopy revealed Fpn-GFP induction did not lead to the
appearance of abberrant RB following Fpn-GFP expression (Figure 3.4), as did Desferal
exposure.
Because expression of the Fpn-GFP was confirmed by fluorescence microscopy,
we investigated whether or not iron levels were altered by Fpn-GFP expression by
measuring levels of ferritin. Ferritin is the primary eukaryotic intracellular iron storage
protein, and its levels are tightly regulated by iron level, making it a convenient and
effective target for assaying relative cellular iron levels in eukaryotes. Contrary to the
observation of the Kaplan laboratory (Nemeth and others 2004), we saw no statistically
significant decrease in iron level following Fpn-GFP induction as measured by ferritin
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expression (Figure 3.5B), while, as expected, Desferal-exposure led to a dosedependent decrease in ferritin levels (Figure 3.5A). While it is possible that the FpnGFP-transfected cell line lost the ability to express functional protein during cell passage
(while retaining GFP fluorescence), the most likely explanation for our differing results is
the use of iron citrate by the Kaplan laboratory to pre-load host cells with iron prior to
inducing Fpn-GFP expression. The recombinant Fpn-GFP protein may only function
efficiently when intracellular iron levels are high; however, pre-loading host cells with
iron is not a biologically relevant model for studying iron restriction of chlamydiae. In a
recent publication, the Kaplan laboratory demonstrated a decreased ability of
chlamydiae to multiply in cells expressing Fpn-GFP, again following pre-incubation of
host cells with ferric citrate (Paradkar and others 2008). While not their intention,
Paradkar and others have demonstrated that increased iron availability (via ferric citrate
pre-incubation) is beneficial to chlamydial replication compared to basal iron levels
(reached through induction of Fpn-GFP).
The third study used proteomic tools to identify chlamydial proteins showing
increased expression during intracellular growth in iron-restricted host cells, followed by
analysis of transcripts encoding a subset of these proteins. The model for iron
restriction of chlamydiae consisted of pre-starving HEC-1B cells with 50 µM Desferal 24
h prior to infection and maintaining this exposure until lysates were collected. Although
iron-responsive proteins have been identified in C. trachomatis by a proteomic approach
previously, the goals and approach of the current study differs. The primary objective of
Raulston (1997) was to establish that chlamydiae require iron, and one way in which
this was demonstrated was through identifying that alterations could be found in the
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5proteome following iron restriction. EB were Renografin-purified from iron restricted
cultures and the end point levels of proteins radiolabeled throughout the developmental
cycle were examined. The current study’s approach is more focused on protein
expression profile during intracellular growth; RB proteins were radiolabeled over a
limited duration and harvested during mid-developmental cycle to preserve expression
profiles of proteins expressed specifically during iron restricted growth.
In order to demonstrate Desferal-exposed chlamydiae were indeed starved for
iron, the ferritin assay was again used to investigate the iron level of the model system.
Analysis revealed an approximately 50% decrease in ferritin level following incubation in
Desferal-exposed HEC-1B cells, validating this model for restricted iron to chlamydiae
(Figure 4.1).
To generate protein expression profiles of chlamydiae grown in iron-restricted
and iron-replete host cells, chlamydial proteins were metabolically radiolabeled from 22
to 24 hpi. The timing of radiolabeling is a critical consideration because only de novo
protein synthesis is detected and protein expression profiles should fluctuate throughout
the developmental cycle according to the stage-specific needs of chlamydiae. This
timeframe was selected because it is during exponential growth of chlamydiae, when
the need for iron would be greatest. Furthermore, a shorter labeling period is
preferable, because longer incubations tend to allow greater eukaryotic incorporation of
radiolabeled amino acids, even in the presence of the eukaryotic protein synthesis
inhibitor cycloheximide.
Following collection and processing of protein samples, proteins were separated
by 2D-PAGE, gels were dried and exposed to phosphor screens, and the screens were
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scanned by phosphorimager. Figure 4.2 shows the protein profiles generated under
iron-replete and iron-restricted conditions. Dymension 2D analysis software was used
to match protein spots across replicates and to measure spot volumes. Fold-change of
iron responsive proteins was determined by analysis of two replicate gels from each of
four independent experiments.
In order to obtain protein identities for species showing an increase in expression
following iron-restricted growth, spots were excised from preparative gels and submitted
for mass spectrometric analysis. Preparative gels consisted of a reduced amount of
radiolabeled sample along with a maximal load (2-3 mg of total protein per gel) of
unlabeled Percoll-purified EB. Because mid cycle-expressed proteins would be most
highly expressed in RB, purified RB would be the most logical starting material,
however, the lower purity of Renografin-purified RB limited the amount of chlamydial
protein that could be gel separated due to the relatively high abundance of eukaryotic
protein. The radiolabeled and purified EB sample was separated by 2D-PAGE,
Coomassie stained, dried, and exposed to x-ray film. Coomassie-stained spots
corresponding to spots on x-ray film were excised and sent to the Columbia University
Protein Core Facility for identification by liquid chromatography-tandem mass
spectrometry.
Of the 25 chlamydial proteins shown to increase in expression during ironrestricted growth, 10 proteins were identified by mass spectrometry (Table 4.2). Mowse
scores, which indicate the confidence level that peptides matching the identified protein
is not random, confirmed the protein identification for each sample, and these results
were further checked by matching to predicted isoelectric points and molecular weights
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for these proteins. Figure 4.3 shows images of each protein from a representative 2D
gel along with the normalized spot volumes as provided by Dymension.
In order to investigate changes in mRNA levels in the chlamydial response to iron
restriction, specific qPCR primers were designed for transcripts encoding five of the
proteins identified as iron responsive in this study: AhpC, DevB, FabF, CADD, and
CT538 (Table 4.1). The genes ahpC, devB, and fabF were selected because of their
iron-responsiveness in other bacteria and their involvement with the oxidative stress
response. Transcription of cadd was analyzed because its putative role in chlamydial
virulence through modulation of host cell death, and ct538 was examined because it is
uncharacterized and may hold a significant function under iron restriction.
In addition to regulation at the transcriptional level, such as via Fur, regulation at
the post-transcriptional level is a well-defined mechanism used to regulate ironresponsive gene expression in eukaryotes, in which iron regulatory proteins bind to iron
responsive elements on untranslated regions of regulated mRNA species; binding at the
5’ tail prevents translation of the transcript, while binding the 3’ tail confers increased
stability to the transcript (Levenson and Tassabehji 2004). Evidence for similar
mechanisms is emerging in bacteria as well, such as the small RNA RyhB in E. coli,
which directs the degradation of several iron-requiring proteins during iron restriction
(Kadner 2005; Masse and Arguin 2005).
RNA and DNA were separately purified from iron-restricted or iron-replete
Chlamydia-infected cell lysates collected at 6, 12, 18, 24, 36, and 48 hpi. qPCR was
used to measure reverse transcribed cDNA or genomic DNA, and chlamydial transcript
levels were normalized to chlamydial chromosome copy number. Chlamydial
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chromosomes were also normalized to total DNA content of samples, to account for
host cell number variation and DNA isolation efficiency. Transcript levels for all five
examined genes peaked at 18 hpi (Fig. 4.4), which corresponds to high expression of
these proteins during radiolabeling, conducted at 22-24 hpi.
Mid-cycle transcript levels increased for each transcript in samples from ironrestricted chlamydiae compared to samples from iron-replete chlamydiae at either 18 or
24 hpi (Fig. 4.4). While transcript levels of ahpC, devB, fabF, and ct538 peaked at
similar levels under both growth conditions at 18 hpi, samples from iron-restricted
chlamydiae demonstrated a delayed decrease in transcript level at 24 hpi compared to
samples from iron-replete chlamydiae. Transcript levels of cadd were higher at 18 hpi
in samples from iron-restricted cultures compared to iron-replete cultures.
Protein expression differences between iron-restricted and iron-replete samples
were higher than transcript level differences, suggesting that the duration of heightened
transcript level may be more important for regulation of protein expression under iron
restriction than changes in maximal transcript levels. Whether this transcript pattern is
the result of derepression due to inactivation of DcrA under reduced iron levels or
increased transcript stability is unclear and should be explored further.
This dissertation project has begun to address the protein-level response of C.
trachomatis to an iron-limited environment. While the pathways used by chlamydiae to
obtain iron have not been elucidated, the findings of this project support the concept
that chlamydiae require iron and the restriction of iron availability alters their metabolic
activity. Because several iron responsive proteins identified in this dissertation possess
functions involved in the response to oxidative stress, it is apparent that the chlamydial
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responses to iron restriction and oxidative stress are connected. This is not surprising,
because the response to iron restriction and oxidative stress are inter-related and even
co-regulated in bacteria and eukaryotes (Hantke 2001; Cairo and others 2002; Raulston
2006). The reason for this connection likely lies in that iron uptake is upregulated upon
iron restriction, introducing an increase of iron in the labile pool; this necessitates
upregulating oxidative damage defense mechanisms in light of the increase of reactive
species. Also, co-regulation of these responses could be due to induction of a general
stress response, considering the plurality of effects iron starvation would have on
cellular pathways of the bacteria. Additionally, the chlamydial response to reduced iron
and oxidative damage may be linked as an adaptation to the immune response to
infection. Interferon-γ is known to play an important role in the immune response to
chlamydial infection, and exposure of host cells to this compound triggers production of
nitric oxide and reduction of iron levels. Furthermore, some chlamydial strains,
particularly LGV, are capable of infecting macrophages, which actively remove iron from
intracellular compartments using the Nramp1 efflux pump (Forbes and Gros 2001), and
expose invading bacteria to an oxidative burst; co-regulation of these pathways would
be an efficient adaptation. Taken together, these data indicate we are only beginning to
understand how chlamydiae have adapted to satisfying the requirement for iron in the
intracellular compartment, and more details will be required at the molecular level
before we can construct a coherent model of the chlamydial response to iron restriction.
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